|
x
|
Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
o
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Large accelerated filer
|
o
|
Accelerated filer
|
x
|
Non-accelerated filer
|
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
|
Emerging growth company
|
o
|
|
|
|
|
Page
|
|
|
||
|
Item 1.
|
Business
|
|
|
Item 1A.
|
Risk Factors
|
|
|
Item 1B.
|
Unresolved Staff Comments
|
|
|
Item 2.
|
Properties
|
|
|
Item 3.
|
Legal Proceedings
|
|
|
Item 4.
|
Mine Safety Disclosures
|
|
|
|
|
|
PA
RT II.
|
|
|
|
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
|
|
Item 6.
|
Selected Financial Data
|
|
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
|
Item 9A.
|
Controls and Procedures
|
|
|
Item 9B.
|
Other Information
|
|
|
|
|
|
PART III.
|
|
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
|
|
Item 11.
|
Executive Compensation
|
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence
|
|
|
Item 14.
|
Principal Accountant Fees and Services
|
|
|
|
|
|
PART IV.
|
|
|
|
|
Item 15.
|
Exhibits, Financial Statement Schedules
|
|
|
Item 16.
|
Form 10-K Summary
|
|
|
|
|
|
SIGNATURES
|
|
ITEM 1.
|
BUSINESS
|
•
|
understanding macroeconomic conditions including the current state of the U.S. and global economies;
|
•
|
understanding the regulatory environment, competition for assets, and the terms and availability of financing;
|
•
|
sector analysis including understanding absolute returns, relative returns and risk-adjusted returns;
|
•
|
security and financing analysis including sensitivity analysis on credit, interest rate volatility, and market value risk; and
|
•
|
managing performance and portfolio risks, including but not limited to interest rate, credit, prepayment, and liquidity risks.
|
|
NOL Available for Use
|
|
Total NOL
|
||||
As of December 31, 2014:
|
$
|
11,739
|
|
|
$
|
89,775
|
|
NOL limitation release for the years ended:
|
|
|
|
||||
December 31, 2015
|
13,451
|
|
|
|
|||
December 31, 2016
|
13,451
|
|
|
|
|||
December 31, 2017
|
13,451
|
|
|
|
|||
NOL used for the years ended:
|
|
|
|
||||
December 31, 2015
|
—
|
|
|
—
|
|
||
December 31, 2016
|
—
|
|
|
—
|
|
||
December 31, 2017
(1)
|
—
|
|
|
—
|
|
||
As of December 31, 2017
|
$
|
52,092
|
|
|
$
|
89,775
|
|
Name (Age)
|
|
Current Title
|
|
Business Experience
|
Byron L. Boston (59)
|
|
Chief Executive Officer, President, Co-Chief Investment Officer, and Director
|
|
Chief Executive Officer and Co-Chief Investment Officer effective January 1, 2014; President and Director since 2012; Chief Investment Officer since 2008.
|
Stephen J. Benedetti (55)
|
|
Executive Vice President, Chief Financial Officer, and Chief Operating Officer
|
|
Executive Vice President and Chief Operating Officer since 2005; Executive Vice President and Chief Financial Officer from 2001 to 2005 and beginning again in 2008.
|
Smriti L. Popenoe (49)
|
|
Executive Vice President and Co-Chief Investment Officer
|
|
Executive Vice President and Co-Chief Investment Officer effective January 1, 2014; Chief Risk Officer of PHH Corporation between 2010 and 2013; Senior Vice President, Balance Sheet Management, of Wachovia Bank, from 2006 to 2009.
|
•
|
market conditions and overall market volatility and liquidity;
|
•
|
regulation of our lenders;
|
•
|
the liquidity of our investments;
|
•
|
the market value of our investments;
|
•
|
the advance rates by our lenders on investment collateral pledged, and;
|
•
|
the willingness of our lenders to finance the types of investments we choose.
|
•
|
The performance of instruments used to hedge may not completely correlate with the performance of the assets or liabilities being hedged;
|
•
|
Interest rate hedging can be expensive, particularly during periods of volatile interest rates;
|
•
|
Available hedging instruments may not correspond directly with the interest rate risk from which we seek protection;
|
•
|
The duration of the hedge may not match the duration of the related asset or liability given management's expectation of future changes in interest rates or a result of the inaccuracies of models in forecasting cash flows on the asset being hedged;
|
•
|
The value of derivatives used for hedging will be adjusted from time to time in accordance with GAAP to reflect changes in fair value, and downward adjustments, or “mark-to-market losses,” would reduce our earnings, shareholders’ equity, and book value;
|
•
|
The amount of income that a REIT may earn from hedging transactions (other than through taxable REIT subsidiaries) to offset interest rate losses may be limited by U.S. federal income tax provisions governing REITs;
|
•
|
The credit quality of the party owing money on the hedge may be downgraded to such an extent that it impairs our ability to sell or assign our side of the hedging transaction; and
|
•
|
The party owing money in the hedging transaction may default on its obligation to pay.
|
•
|
If we make frequent asset sales from our REIT entities to persons deemed customers, we could be viewed as a “dealer,” and thus subject to 100% prohibited transaction taxes or other entity level taxes on income from such transactions.
|
•
|
Compliance with the REIT income and asset requirements may limit the type or extent of hedging that we can undertake and could limit our ability to invest in TBA securities.
|
•
|
Our ability to own non-real estate related assets and earn non-real estate related income is limited. Our ability to own equity interests in other entities is limited. If we fail to comply with these limits, we may be forced to liquidate attractive assets on short notice on unfavorable terms in order to maintain our REIT status.
|
•
|
Our ability to invest in taxable subsidiaries is limited under the REIT rules. Maintaining compliance with this limitation could require us to constrain the growth of future taxable REIT affiliates.
|
•
|
Notwithstanding our NOL carryforward, meeting minimum REIT dividend distribution requirements could reduce our liquidity. Earning non-cash REIT taxable income could necessitate our selling assets, incurring debt, or raising new equity in order to fund dividend distributions.
|
•
|
Stock ownership tests may limit our ability to raise significant amounts of equity capital from one source.
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS
|
ITEM 2.
|
PROPERTIES
|
ITEM 3.
|
LEGAL PROCEEDINGS
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
|
|
|
|
|
Dividends Declared
|
||||
|
High
|
|
Low
|
|
Common Stock
|
|
Series A Preferred Stock
|
|
Series B Preferred Stock
|
2017:
|
|
|
|
|
|
|
|
|
|
First quarter
|
$7.11
|
|
$6.58
|
|
$0.18
|
|
$0.53125
|
|
$0.4765625
|
Second quarter
|
$7.37
|
|
$6.69
|
|
$0.18
|
|
$0.53125
|
|
$0.4765625
|
Third quarter
|
$7.41
|
|
$6.76
|
|
$0.18
|
|
$0.53125
|
|
$0.4765625
|
Fourth quarter
|
$7.40
|
|
$6.86
|
|
$0.18
|
|
$0.53125
|
|
$0.4765625
|
|
|
|
|
|
|
|
|
|
|
2016:
|
|
|
|
|
|
|
|
|
|
First quarter
|
$6.92
|
|
$5.22
|
|
$0.21
|
|
$0.53125
|
|
$0.4765625
|
Second quarter
|
$7.00
|
|
$6.33
|
|
$0.21
|
|
$0.53125
|
|
$0.4765625
|
Third quarter
|
$7.61
|
|
$6.56
|
|
$0.21
|
|
$0.53125
|
|
$0.4765625
|
Fourth quarter
|
$7.21
|
|
$6.49
|
|
$0.21
|
|
$0.53125
|
|
$0.4765625
|
|
Tax Characterization
|
|
Total Dividends Declared Per Share
|
||||||||||||
|
Ordinary
|
|
Capital Gain
|
|
Return of Capital
|
|
|||||||||
Common dividends declared:
|
|
|
|
|
|
|
|
||||||||
Year ended December 31, 2017
|
$
|
0.2151908
|
|
|
$
|
—
|
|
|
$
|
0.5048092
|
|
|
$
|
0.7200
|
|
Year ended December 31, 2016
|
$
|
0.2572877
|
|
|
$
|
—
|
|
|
$
|
0.5827123
|
|
|
$
|
0.8400
|
|
|
|
|
|
|
|
|
|
||||||||
Preferred Series A dividends declared:
|
|
|
|
|
|
|
|
||||||||
Year ended December 31, 2017
|
$
|
2.1250000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2.1250
|
|
Year ended December 31, 2016
|
$
|
2.1250000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2.1250
|
|
|
|
|
|
|
|
|
|
||||||||
Preferred Series B dividends declared:
|
|
|
|
|
|
|
|
||||||||
Year ended December 31, 2017
|
$
|
1.9062500
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1.9063
|
|
Year ended December 31, 2016
|
$
|
1.9062500
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1.9063
|
|
|
Cumulative Total Stockholder Returns as of December 31,
|
|||||||||||||||||
Index
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
||||||||||||
Dynex Capital, Inc. Common Stock
|
$
|
100.00
|
|
$
|
95.44
|
|
$
|
110.69
|
|
$
|
97.44
|
|
$
|
118.12
|
|
$
|
134.46
|
|
S&P 500
|
$
|
100.00
|
|
$
|
132.36
|
|
$
|
150.43
|
|
$
|
152.51
|
|
$
|
170.70
|
|
$
|
207.92
|
|
Bloomberg Mortgage REIT Index
|
$
|
100.00
|
|
$
|
97.61
|
|
$
|
116.56
|
|
$
|
105.15
|
|
$
|
128.39
|
|
$
|
154.43
|
|
SNL U.S. Finance REIT Index
|
$
|
100.00
|
|
$
|
96.58
|
|
$
|
110.61
|
|
$
|
101.43
|
|
$
|
124.94
|
|
$
|
145.78
|
|
|
As of/For the Year Ended December 31,
|
||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Balance Sheet Data:
|
($ in thousands except per share data)
|
||||||||||||||||||
Mortgage-backed securities
|
$
|
3,026,989
|
|
|
$
|
3,212,084
|
|
|
$
|
3,493,701
|
|
|
$
|
3,516,239
|
|
|
$
|
4,018,161
|
|
U.S. Treasuries
|
146,530
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total assets
|
3,305,778
|
|
|
3,397,731
|
|
|
3,670,048
|
|
|
3,688,311
|
|
|
4,217,137
|
|
|||||
Repurchase agreements
|
2,565,902
|
|
|
2,898,952
|
|
|
2,589,420
|
|
|
3,013,110
|
|
|
3,580,754
|
|
|||||
Total liabilities
|
2,748,720
|
|
|
2,930,547
|
|
|
3,178,023
|
|
|
3,081,009
|
|
|
3,631,261
|
|
|||||
Shareholders’ equity
|
557,058
|
|
|
467,184
|
|
|
492,025
|
|
|
607,302
|
|
|
585,876
|
|
|||||
Common shares outstanding
|
55,831,549
|
|
|
49,153,463
|
|
|
49,047,335
|
|
|
54,739,111
|
|
|
54,310,484
|
|
|||||
Book value per common share
|
$
|
7.34
|
|
|
$
|
7.18
|
|
|
$
|
7.71
|
|
|
$
|
9.02
|
|
|
$
|
8.69
|
|
Leverage
(1)
|
6.4
|
|
|
6.3
|
|
|
6.5
|
|
|
5.1
|
|
|
6.2
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Statement of Comprehensive Income Data:
|
|
|
|
|
|
|
|
|
|||||||||||
Interest income
|
$
|
94,502
|
|
|
$
|
91,898
|
|
|
$
|
100,244
|
|
|
$
|
105,644
|
|
|
$
|
127,132
|
|
Interest expense
(2)
|
36,178
|
|
|
25,231
|
|
|
22,605
|
|
|
25,915
|
|
|
39,028
|
|
|||||
Net interest income
(2)
|
58,324
|
|
|
66,667
|
|
|
77,639
|
|
|
79,729
|
|
|
88,104
|
|
|||||
(Loss) gain on sale of investments, net
|
(11,530
|
)
|
|
(4,238
|
)
|
|
(978
|
)
|
|
16,223
|
|
|
3,354
|
|
|||||
Gain (loss) on derivative instruments, net
(2)
|
3,044
|
|
|
(5,606
|
)
|
|
(43,128
|
)
|
|
(53,393
|
)
|
|
(10,076
|
)
|
|||||
General and administrative expenses
|
(15,819
|
)
|
|
(14,707
|
)
|
|
(17,668
|
)
|
|
(16,007
|
)
|
|
(13,058
|
)
|
|||||
Net income to common shareholders
(2)
|
23,099
|
|
|
33,914
|
|
|
7,368
|
|
|
18,630
|
|
|
60,167
|
|
|||||
Comprehensive income (loss) to common shareholders
|
47,011
|
|
|
14,073
|
|
|
(26,716
|
)
|
|
73,762
|
|
|
(26,160
|
)
|
|||||
Average common shares outstanding
|
50,416,520
|
|
|
49,114,497
|
|
|
52,847,197
|
|
|
54,701,485
|
|
|
54,647,643
|
|
|||||
Net income per common share-basic and diluted
|
$
|
0.46
|
|
|
$
|
0.69
|
|
|
$
|
0.14
|
|
|
$
|
0.34
|
|
|
$
|
1.10
|
|
Comprehensive income (loss) per common share-basic and diluted
|
$
|
0.93
|
|
|
$
|
0.29
|
|
|
$
|
(0.51
|
)
|
|
$
|
1.35
|
|
|
$
|
(0.48
|
)
|
Dividends declared per share:
|
|
|
|
|
|
|
|
|
|
||||||||||
Common
|
$
|
0.72
|
|
|
$
|
0.84
|
|
|
$
|
0.96
|
|
|
$
|
1.00
|
|
|
$
|
1.12
|
|
Series A Preferred
|
$
|
2.13
|
|
|
$
|
2.13
|
|
|
$
|
2.13
|
|
|
$
|
2.13
|
|
|
$
|
2.13
|
|
Series B Preferred
|
$
|
1.91
|
|
|
$
|
1.91
|
|
|
$
|
1.91
|
|
|
$
|
1.91
|
|
|
$
|
0.94
|
|
(1)
|
Leverage is calculated by dividing total liabilities by total shareholders’ equity as of each period end except for December 31, 2017 which includes TBA long positions at cost (as if settled) of
$829.4 million
within total liabilities.
|
(2)
|
Results for these amounts for the year ended December 31, 2013 are not directly comparable to other periods presented because the Company discontinued cash flow hedge accounting for its derivative instruments effective June 30, 2013.
|
|
For the Year Ended December 31,
|
||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Other Data Including Non-GAAP Financial Measures:
|
($ in thousands except per share data)
|
||||||||||||||||||
Adjusted interest expense
(1)
|
$
|
39,863
|
|
|
$
|
27,943
|
|
|
$
|
24,836
|
|
|
$
|
27,345
|
|
|
$
|
42,783
|
|
Adjusted net interest income
(1)
|
63,817
|
|
|
63,955
|
|
|
75,408
|
|
|
78,299
|
|
|
84,349
|
|
|||||
Core net operating income to common shareholders
(1)
|
37,003
|
|
|
40,943
|
|
|
49,174
|
|
|
54,162
|
|
|
63,786
|
|
|||||
Core net operating income per common share
(1)
|
$
|
0.73
|
|
|
$
|
0.83
|
|
|
$
|
0.93
|
|
|
$
|
0.99
|
|
|
$
|
1.17
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Average interest earning assets
|
$
|
3,052,372
|
|
|
$
|
3,236,903
|
|
|
$
|
3,685,936
|
|
|
$
|
3,822,870
|
|
|
$
|
4,290,073
|
|
Average balance of borrowings
|
2,697,601
|
|
|
2,912,426
|
|
|
3,269,711
|
|
|
3,347,701
|
|
|
3,797,845
|
|
|||||
Effective yield
(2)
|
3.06
|
%
|
|
2.82
|
%
|
|
2.71
|
%
|
|
2.76
|
%
|
|
2.96
|
%
|
|||||
Cost of funds
(2)
|
1.32
|
%
|
|
0.85
|
%
|
|
0.68
|
%
|
|
0.76
|
%
|
|
1.01
|
%
|
|||||
Net interest spread
|
1.74
|
%
|
|
1.97
|
%
|
|
2.03
|
%
|
|
2.00
|
%
|
|
1.95
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted cost of funds
(1)
|
1.46
|
%
|
|
0.94
|
%
|
|
0.75
|
%
|
|
0.81
|
%
|
|
1.10
|
%
|
|||||
Adjusted net interest spread
(3)
|
1.64
|
%
|
|
1.88
|
%
|
|
1.96
|
%
|
|
1.95
|
%
|
|
1.86
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Effective yield by MBS type:
|
|
|
|
|
|
|
|
|
|
||||||||||
Agency RMBS
|
1.98
|
%
|
|
1.71
|
%
|
|
1.71
|
%
|
|
1.81
|
%
|
|
1.99
|
%
|
|||||
Non-Agency RMBS
|
3.94
|
%
|
|
3.61
|
%
|
|
3.64
|
%
|
|
6.93
|
%
|
|
5.22
|
%
|
|||||
Agency CMBS
|
2.80
|
%
|
|
2.95
|
%
|
|
3.08
|
%
|
|
3.62
|
%
|
|
3.59
|
%
|
|||||
Non-Agency CMBS
|
12.03
|
%
|
|
6.43
|
%
|
|
5.74
|
%
|
|
5.44
|
%
|
|
5.63
|
%
|
|||||
Agency CMBS IO
|
4.41
|
%
|
|
4.21
|
%
|
|
3.88
|
%
|
|
4.35
|
%
|
|
4.95
|
%
|
|||||
Non-Agency CMBS IO
|
4.32
|
%
|
|
4.11
|
%
|
|
3.98
|
%
|
|
4.08
|
%
|
|
4.82
|
%
|
|
For the Year Ended December 31,
|
||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Reconciliations of GAAP to Non-GAAP Financial Measures:
|
($ in thousands except per share data)
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP net income to common shareholders
|
$
|
23,099
|
|
|
$
|
33,914
|
|
|
$
|
7,368
|
|
|
$
|
18,630
|
|
|
$
|
60,167
|
|
Less:
|
|
|
|
|
|
|
|
|
|
||||||||||
(Accretion) amortization of de-designated cash flow hedges
(1)
|
(268
|
)
|
|
(251
|
)
|
|
3,499
|
|
|
6,788
|
|
|
5,193
|
|
|||||
Change in fair value of derivative instruments, net
(2)
|
2,717
|
|
|
3,145
|
|
|
37,398
|
|
|
45,175
|
|
|
1,128
|
|
|||||
Loss (gain) on sale of investments, net
|
11,530
|
|
|
4,238
|
|
|
978
|
|
|
(16,223
|
)
|
|
(3,354
|
)
|
|||||
Fair value adjustments, net
|
(75
|
)
|
|
(103
|
)
|
|
(69
|
)
|
|
(208
|
)
|
|
652
|
|
|||||
Core net operating income to common shareholders
|
$
|
37,003
|
|
|
$
|
40,943
|
|
|
$
|
49,174
|
|
|
$
|
54,162
|
|
|
$
|
63,786
|
|
Average common shares outstanding
|
50,416,520
|
|
|
49,114,497
|
|
|
52,847,197
|
|
|
54,701,485
|
|
|
54,647,643
|
|
|||||
Core net operating income per common share
|
$
|
0.73
|
|
|
$
|
0.83
|
|
|
$
|
0.93
|
|
|
$
|
0.99
|
|
|
$
|
1.17
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP interest expense
|
$
|
36,178
|
|
|
$
|
25,231
|
|
|
$
|
22,605
|
|
|
$
|
25,915
|
|
|
$
|
39,028
|
|
Add: net periodic interest costs of derivative instruments
|
3,417
|
|
|
2,461
|
|
|
5,730
|
|
|
8,218
|
|
|
8,948
|
|
|||||
Less: accretion (amortization) of de-designated cash flow hedges
(1)
|
268
|
|
|
251
|
|
|
(3,499
|
)
|
|
(6,788
|
)
|
|
(5,193
|
)
|
|||||
Adjusted interest expense
|
$
|
39,863
|
|
|
$
|
27,943
|
|
|
$
|
24,836
|
|
|
$
|
27,345
|
|
|
$
|
42,783
|
|
Average balance of borrowings
|
2,697,601
|
|
|
2,912,426
|
|
|
3,269,711
|
|
|
3,347,701
|
|
|
3,797,845
|
|
|||||
Adjusted cost of funds
|
1.46
|
%
|
|
0.94
|
%
|
|
0.75
|
%
|
|
0.81
|
%
|
|
1.10
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP net interest income
|
$
|
58,324
|
|
|
$
|
66,667
|
|
|
$
|
77,639
|
|
|
$
|
79,729
|
|
|
$
|
88,104
|
|
Add:
|
|
|
|
|
|
|
|
|
|
||||||||||
TBA drop income
|
9,178
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net periodic interest costs of derivative instruments
|
(3,417
|
)
|
|
(2,461
|
)
|
|
(5,730
|
)
|
|
(8,218
|
)
|
|
(8,948
|
)
|
|||||
Less: accretion (amortization) of de-designated cash flow hedges
(1)
|
(268
|
)
|
|
(251
|
)
|
|
3,499
|
|
|
6,788
|
|
|
5,193
|
|
|||||
Adjusted net interest income
|
$
|
63,817
|
|
|
$
|
63,955
|
|
|
$
|
75,408
|
|
|
$
|
78,299
|
|
|
$
|
84,349
|
|
Adjusted net interest spread
|
1.64
|
%
|
|
1.88
|
%
|
|
1.96
|
%
|
|
1.95
|
%
|
|
1.86
|
%
|
(1)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the amortization (accretion) of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
(2)
|
Amount includes unrealized gains and losses from changes in fair value of derivatives and realized gains and losses on terminated derivatives and excludes net periodic interest costs incurred on effective interest rate swaps outstanding during the period.
|
ITEM 7.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Investment Type:
|
|
12/31/2016
|
|
3/31/2017
|
|
6/30/2017
|
|
9/30/2017
|
|
12/31/2017
|
|||||
Fixed 30 year FN 3% (Fixed-rate Agency RMBS)
|
|
36
|
|
|
34
|
|
|
36
|
|
|
29
|
|
|
26
|
|
Fixed 30 year FN 4% (Fixed-rate Agency RMBS)
|
|
33
|
|
|
27
|
|
|
31
|
|
|
29
|
|
|
26
|
|
Agency ARM 5/1 (Adjustable-rate Agency RMBS)
|
|
19
|
|
|
24
|
|
|
21
|
|
|
20
|
|
|
16
|
|
Agency DUS (Agency CMBS)
|
|
76
|
|
|
67
|
|
|
68
|
|
|
64
|
|
|
56
|
|
Freddie K AAA IO (Agency CMBS IO)
|
|
200
|
|
|
150
|
|
|
145
|
|
|
120
|
|
|
100
|
|
AAA CMBS IO (Non-Agency CMBS IO)
|
|
195
|
|
|
145
|
|
|
110
|
|
|
120
|
|
|
100
|
|
Freddie K B (Non-Agency CMBS)
|
|
295
|
|
|
220
|
|
|
165
|
|
|
170
|
|
|
165
|
|
(1)
|
Includes securities pending settlement as of December 31, 2017.
|
(2)
|
Includes long positions in TBAs used for investment purposes at their implied market value as if settled and excludes short positions in TBAs used for economic hedging purposes. All TBAs are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||
($ in thousands)
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
RMBS:
|
|
|
|
|
|
|
|
|
||||||||
Agency RMBS, 30 year fixed-rate
(1)
|
|
$
|
903,270
|
|
|
$
|
898,678
|
|
|
$
|
—
|
|
|
$
|
—
|
|
TBAs, 30 year fixed-rate
(2)
|
|
829,425
|
|
|
830,908
|
|
|
—
|
|
|
—
|
|
||||
Agency RMBS - adjustable rate
|
|
289,304
|
|
|
285,583
|
|
|
1,214,324
|
|
|
1,201,205
|
|
||||
Non-Agency RMBS
|
|
1,070
|
|
|
1,091
|
|
|
33,548
|
|
|
33,562
|
|
||||
|
|
2,023,069
|
|
|
2,016,260
|
|
|
1,247,872
|
|
|
1,234,767
|
|
||||
CMBS and CMBS IO:
|
|
|
|
|
|
|
|
|
||||||||
Fixed-rate Agency CMBS
|
|
$
|
1,134,409
|
|
|
$
|
1,124,351
|
|
|
$
|
1,166,454
|
|
|
$
|
1,144,555
|
|
Non-Agency CMBS
|
|
22,466
|
|
|
24,764
|
|
|
72,749
|
|
|
78,216
|
|
||||
Agency CMBS IO
|
|
375,361
|
|
|
380,306
|
|
|
411,737
|
|
|
411,898
|
|
||||
Non-Agency CMBS IO
|
|
308,472
|
|
|
312,216
|
|
|
346,155
|
|
|
342,648
|
|
||||
|
|
1,840,708
|
|
|
1,841,637
|
|
|
1,997,095
|
|
|
1,977,317
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Total MBS portfolio including TBA dollar roll positions
|
|
$
|
3,863,777
|
|
|
$
|
3,857,897
|
|
|
$
|
3,244,967
|
|
|
$
|
3,212,084
|
|
(1)
|
Includes securities pending settlement as of December 31, 2017.
|
(2)
|
Consists of long positions in TBAs used for investment purposes at their implied cost basis and implied market value, respectively, as if settled and excludes short positions in TBAs used for economic hedging purposes. All TBAs are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.
|
|
Agency CMBS
|
|
Agency RMBS
|
|
CMBS IO
(3)
|
|
Non-Agency Other
(4)
|
|
Total
|
||||||||||||||
($ in thousands)
|
|
30-Year Fixed Rate
(1) (2)
|
|
Adjustable Rate
|
|
|
|
||||||||||||||||
Balance as of December 31, 2016
|
$
|
1,144,555
|
|
|
$
|
—
|
|
|
$
|
1,201,205
|
|
|
$
|
754,546
|
|
|
$
|
111,778
|
|
|
$
|
3,212,084
|
|
Purchases
|
286,275
|
|
|
1,745,684
|
|
|
—
|
|
|
72,017
|
|
|
—
|
|
|
2,103,976
|
|
||||||
Principal payments
|
(61,610
|
)
|
|
(11,106
|
)
|
|
(188,018
|
)
|
|
—
|
|
|
(34,586
|
)
|
|
(295,320
|
)
|
||||||
Sales
|
(252,759
|
)
|
|
(1,111
|
)
|
|
(727,841
|
)
|
|
—
|
|
|
(50,871
|
)
|
|
(1,032,582
|
)
|
||||||
(Amortization) accretion
|
(4,347
|
)
|
|
(773
|
)
|
|
(9,161
|
)
|
|
(146,075
|
)
|
|
2,696
|
|
|
(157,660
|
)
|
||||||
Change in fair value
|
12,237
|
|
|
(3,108
|
)
|
|
9,398
|
|
|
12,034
|
|
|
(3,162
|
)
|
|
27,399
|
|
||||||
Balance as of December 31, 2017
|
$
|
1,124,351
|
|
|
$
|
1,729,586
|
|
|
$
|
285,583
|
|
|
$
|
692,522
|
|
|
$
|
25,855
|
|
|
$
|
3,857,897
|
|
(1)
|
Includes securities pending settlement as of December 31, 2017.
|
(2)
|
Includes long positions in TBAs used for investment purposes at their implied market value as if settled and excludes short positions in TBAs used for economic hedging purposes. All TBAs are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.
|
(3)
|
Includes Agency and non-Agency issued CMBS IO.
|
(4)
|
Includes non-Agency CMBS and RMBS.
|
|
|
December 31, 2017
|
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
Weighted Average Based on Par
|
|||||||||||||||||
Coupon
|
|
Par
|
|
Amortized Cost/Implied Cost Basis
(1)(3)
|
|
Fair
Value
(2)(3)
|
|
Average Original Loan
Balance
(4)
|
|
Loan Age
(in months)
(4)
|
|
3 Month
CPR
(4)(5)
|
|
Duration
(6)
|
|||||||||||
($ in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
30-year fixed-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3.0%
|
|
$
|
244,374
|
|
|
$
|
246,155
|
|
|
$
|
244,818
|
|
|
$
|
233,584
|
|
|
13
|
|
|
5.0
|
%
|
|
6.30
|
|
4.0%
|
|
623,293
|
|
|
657,114
|
|
|
653,860
|
|
|
274,965
|
|
|
4
|
|
|
4.0
|
%
|
|
3.91
|
|
||||
TBA 4.0%
|
|
795,000
|
|
|
829,425
|
|
|
830,908
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
2.95
|
|
||||
Total 30-year fixed-rate
|
|
$
|
1,662,667
|
|
|
$
|
1,732,694
|
|
|
$
|
1,729,586
|
|
|
$
|
263,310
|
|
|
6
|
|
|
4.3
|
%
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjustable-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3.1%
(7)
|
|
$
|
278,886
|
|
|
$
|
289,305
|
|
|
$
|
285,583
|
|
|
$
|
271,516
|
|
|
74
|
|
|
16.0
|
%
|
|
2.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Agency RMBS (including TBA dollar roll positions)
|
|
$
|
1,941,553
|
|
|
$
|
2,021,999
|
|
|
$
|
2,015,169
|
|
|
$
|
265,306
|
|
|
23
|
|
|
7.1
|
%
|
|
3.58
|
|
(1)
|
Implied cost basis of TBA dollar roll positions represents the forward price to be paid for the underlying Agency MBS as if settled.
|
(2)
|
Fair value of TBA dollar roll positions is the implied market value of the underlying Agency security as of the end of the period if settled.
|
(3)
|
The net carrying value of TBA dollar roll positions, which is the difference between their implied market value and implied cost basis, was
$1.5 million
as of
December 31, 2017
and is included on the consolidated balance sheet within “derivative assets”.
|
(4)
|
TBA dollar roll positions are excluded from this calculation as they do not have a defined weighted-average loan balance or age until mortgages have been assigned to the pool.
|
(5)
|
Constant prepayment rate (“CPR”) represents the 3-month CPR of Agency RMBS held as of date indicated. Securities with no prepayment history are excluded from this calculation.
|
(6)
|
Duration measures the sensitivity of a security's price to the change in interest rates and represents the percent change in price of a security for a 100 basis point increase in interest rates. We calculate duration using third-party financial models and empirical data. Different models and methodologies can produce different estimates of duration for the same securities.
|
(7)
|
Coupon of adjustable-rate Agency RMBS represents the weighted average coupon based on amortized cost.
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||
($ in thousands)
|
Par Value
|
|
Amortized Cost
|
|
Fair Value
|
|
Par Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||||||
Adjustable-rate Agency RMBS by MTR:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
0-12 MTR
|
$
|
43,218
|
|
|
$
|
44,450
|
|
|
$
|
45,504
|
|
|
$
|
335,476
|
|
|
$
|
355,069
|
|
|
$
|
353,887
|
|
13-36 MTR
|
2,026
|
|
|
2,167
|
|
|
2,117
|
|
|
225,272
|
|
|
237,642
|
|
|
235,137
|
|
||||||
37-60 MTR
|
168,980
|
|
|
176,258
|
|
|
172,903
|
|
|
151,578
|
|
|
160,948
|
|
|
157,945
|
|
||||||
Greater than 60 MTR
|
64,662
|
|
|
66,430
|
|
|
65,059
|
|
|
444,932
|
|
|
460,665
|
|
|
454,236
|
|
||||||
Total adjustable-rate Agency RMBS
|
$
|
278,886
|
|
|
$
|
289,305
|
|
|
$
|
285,583
|
|
|
$
|
1,157,258
|
|
|
$
|
1,214,324
|
|
|
$
|
1,201,205
|
|
|
December 31, 2017
|
|
December 31, 2016
|
|||||||||||||||||
($ in thousands)
|
Par Value
|
|
Amortized Cost
|
|
Months to Estimated Maturity
(1)
|
|
Par Value
|
|
Amortized Cost
|
|
Months to Estimated Maturity
(1)
|
|||||||||
Year of Origination:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
2008 and prior
|
$
|
34,065
|
|
|
$
|
31,026
|
|
|
41
|
|
$
|
57,771
|
|
|
$
|
53,161
|
|
|
34
|
|
2009 to 2012
|
106,619
|
|
|
109,234
|
|
|
27
|
|
193,061
|
|
|
198,916
|
|
|
33
|
|||||
2013 to 2014
|
20,237
|
|
|
20,600
|
|
|
82
|
|
42,760
|
|
|
43,176
|
|
|
95
|
|||||
2015
|
468,296
|
|
|
469,657
|
|
|
103
|
|
683,680
|
|
|
687,214
|
|
|
111
|
|||||
2016
|
239,139
|
|
|
240,831
|
|
|
110
|
|
254,781
|
|
|
256,736
|
|
|
122
|
|||||
2017
|
282,112
|
|
|
285,527
|
|
|
118
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
$
|
1,150,468
|
|
|
$
|
1,156,875
|
|
|
99
|
|
$
|
1,232,053
|
|
|
$
|
1,239,203
|
|
|
97
|
(1)
|
Months to estimated maturity is an average weighted by the amortized cost of the investment.
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||
($ in thousands)
|
Amortized Cost
|
|
Fair Value
|
|
Remaining WAL
(1)
|
|
Amortized Cost
|
|
Fair Value
|
|
Remaining WAL
(1)
|
||||||||||
Year of Origination:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2010
|
$
|
6,421
|
|
|
$
|
6,554
|
|
|
13
|
|
|
$
|
9,456
|
|
|
$
|
9,858
|
|
|
19
|
|
2011
|
25,652
|
|
|
26,720
|
|
|
18
|
|
|
35,130
|
|
|
36,897
|
|
|
23
|
|
||||
2012
|
71,615
|
|
|
72,913
|
|
|
22
|
|
|
102,378
|
|
|
103,675
|
|
|
27
|
|
||||
2013
|
103,730
|
|
|
104,568
|
|
|
28
|
|
|
128,891
|
|
|
129,011
|
|
|
33
|
|
||||
2014
|
171,285
|
|
|
173,043
|
|
|
34
|
|
|
201,802
|
|
|
200,260
|
|
|
39
|
|
||||
2015
|
170,663
|
|
|
172,974
|
|
|
40
|
|
|
198,016
|
|
|
194,886
|
|
|
45
|
|
||||
2016
|
82,698
|
|
|
83,444
|
|
|
47
|
|
|
82,219
|
|
|
79,959
|
|
|
87
|
|
||||
2017
|
51,769
|
|
|
52,306
|
|
|
53
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
$
|
683,833
|
|
|
$
|
692,522
|
|
|
36
|
|
|
$
|
757,892
|
|
|
$
|
754,546
|
|
|
42
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||
($ in thousands)
|
Fair Value
|
|
Amount Pledged
|
|
Related Borrowings
|
|
Fair Value
|
|
Amount Pledged
|
|
Related Borrowings
|
||||||||||||
Non-Agency CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
AAA
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
35,405
|
|
|
$
|
35,313
|
|
|
$
|
32,266
|
|
AA
|
—
|
|
|
—
|
|
|
—
|
|
|
14,127
|
|
|
14,105
|
|
|
11,665
|
|
||||||
A
|
18,212
|
|
|
18,212
|
|
|
15,508
|
|
|
18,614
|
|
|
18,549
|
|
|
15,831
|
|
||||||
Below A/Not Rated
|
6,552
|
|
|
—
|
|
|
—
|
|
|
10,070
|
|
|
9,873
|
|
|
7,119
|
|
||||||
|
$
|
24,764
|
|
|
$
|
18,212
|
|
|
$
|
15,508
|
|
|
$
|
78,216
|
|
|
$
|
77,840
|
|
|
$
|
66,881
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Non-Agency CMBS IO:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
AAA
|
$
|
259,155
|
|
|
$
|
259,151
|
|
|
$
|
218,995
|
|
|
$
|
290,092
|
|
|
$
|
289,608
|
|
|
$
|
246,412
|
|
AA
|
42,486
|
|
|
—
|
|
|
—
|
|
|
46,986
|
|
|
45,995
|
|
|
40,026
|
|
||||||
A
|
735
|
|
|
735
|
|
|
641
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Below A/Not Rated
|
9,840
|
|
|
51,685
|
|
|
44,058
|
|
|
5,570
|
|
|
5,536
|
|
|
4,761
|
|
||||||
|
$
|
312,216
|
|
|
$
|
311,571
|
|
|
$
|
263,694
|
|
|
$
|
342,648
|
|
|
$
|
341,139
|
|
|
$
|
291,199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Non-Agency RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Below A/Not Rated
|
$
|
1,091
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
33,562
|
|
|
$
|
31,952
|
|
|
$
|
26,149
|
|
|
$
|
1,091
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
33,562
|
|
|
$
|
31,952
|
|
|
$
|
26,149
|
|
|
Year Ended
|
||||||||||||||||||||
|
December 31,
|
||||||||||||||||||||
|
2017
|
|
2016
|
||||||||||||||||||
($ in thousands)
|
Income
|
|
Average Balance
|
|
Yield
|
|
Income
|
|
Average Balance
|
|
Yield
|
||||||||||
MBS
|
$
|
92,657
|
|
|
$
|
3,006,087
|
|
|
3.07
|
%
|
|
$
|
90,949
|
|
|
$
|
3,214,897
|
|
|
2.82
|
%
|
U.S. Treasuries
|
616
|
|
|
28,848
|
|
|
2.14
|
%
|
|
—
|
|
|
—
|
|
|
—
|
%
|
||||
Mortgage loans held for investment, net
|
698
|
|
|
17,437
|
|
|
4.01
|
%
|
|
856
|
|
|
22,006
|
|
|
3.89
|
%
|
||||
Total from investments
|
93,971
|
|
|
3,052,372
|
|
|
3.06
|
%
|
|
91,805
|
|
|
3,236,903
|
|
|
2.82
|
%
|
||||
Cash and cash equivalents
|
531
|
|
|
|
|
|
|
93
|
|
|
|
|
|
||||||||
Total interest income
|
$
|
94,502
|
|
|
|
|
|
|
$
|
91,898
|
|
|
|
|
|
|
Year Ended
|
||||||||||||
|
December 31,
|
||||||||||||
|
2017
|
|
2016
|
||||||||||
($ in thousands)
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
RMBS:
|
|
|
|
|
|
|
|
||||||
Coupon and scheduled amortization
|
$
|
21,519
|
|
|
2.18
|
%
|
|
$
|
27,670
|
|
|
1.91
|
%
|
Prepayment adjustments
(1)
|
(1,741
|
)
|
|
(0.18
|
)%
|
|
(1,962
|
)
|
|
(0.13
|
)%
|
||
|
$
|
19,778
|
|
|
2.00
|
%
|
|
$
|
25,708
|
|
|
1.78
|
%
|
Average balance
(2)
|
$
|
987,107
|
|
|
|
|
$
|
1,446,479
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|||||
CMBS:
|
|
|
|
|
|
|
|
||||||
Coupon and scheduled amortization
|
$
|
38,001
|
|
|
2.93
|
%
|
|
$
|
32,918
|
|
|
3.18
|
%
|
Prepayment adjustments
(1)
|
2,701
|
|
|
0.21
|
%
|
|
1,256
|
|
|
0.12
|
%
|
||
|
$
|
40,702
|
|
|
3.14
|
%
|
|
$
|
34,174
|
|
|
3.30
|
%
|
Average balance
(2)
|
$
|
1,282,207
|
|
|
|
|
|
$
|
1,021,960
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
CMBS IO:
|
|
|
|
|
|
|
|
|
|
||||
Coupon and scheduled amortization
|
$
|
27,458
|
|
|
3.73
|
%
|
|
$
|
28,172
|
|
|
3.77
|
%
|
Prepayment adjustments
(1)
|
4,719
|
|
|
0.64
|
%
|
|
2,895
|
|
|
0.39
|
%
|
||
|
$
|
32,177
|
|
|
4.37
|
%
|
|
$
|
31,067
|
|
|
4.16
|
%
|
Average balance
(2)
|
$
|
736,773
|
|
|
|
|
|
$
|
746,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total MBS interest income and effective yield:
|
$
|
92,657
|
|
|
3.07
|
%
|
|
$
|
90,949
|
|
|
2.82
|
%
|
|
|
|
|
|
|
|
|
|
|||||
Total average balance
(2)
:
|
$
|
3,006,087
|
|
|
|
|
$
|
3,214,897
|
|
|
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for RMBS and prepayment compensation, net of amortization for CMBS and CMBS IO.
|
(2)
|
Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.
|
|
Year Ended
|
||||||||||||||
|
December 31, 2017 Compared to December 31, 2016
|
||||||||||||||
|
Increase (Decrease) in Interest Income
|
|
Due to Change In
|
||||||||||||
($ in thousands)
|
|
Average Balance
|
|
Coupon and Scheduled Amortization
|
|
Prepayment Adjustments
(1)
|
|||||||||
RMBS
|
$
|
(5,930
|
)
|
|
$
|
(6,507
|
)
|
|
$
|
356
|
|
|
$
|
221
|
|
CMBS
|
6,528
|
|
|
5,033
|
|
|
50
|
|
|
1,445
|
|
||||
CMBS IO
|
1,110
|
|
|
(364
|
)
|
|
(350
|
)
|
|
1,824
|
|
||||
Total
|
$
|
1,708
|
|
|
$
|
(1,838
|
)
|
|
$
|
56
|
|
|
$
|
3,490
|
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for RMBS and prepayment compensation, net of amortization for CMBS and CMBS IO.
|
|
Year Ended
|
||||||||||||||
|
December 31, 2017 Compared to December 31, 2016
|
||||||||||||||
|
Increase (Decrease) in Interest Income
|
|
Due to Change In
|
||||||||||||
($ in thousands)
|
|
Average Balance
|
|
Coupon and Scheduled Amortization
|
|
Prepayment Adjustments
(1)
|
|||||||||
Adjustable-rate Agency RMBS
|
$
|
(10,512
|
)
|
|
$
|
(11,069
|
)
|
|
$
|
357
|
|
|
$
|
200
|
|
Fixed-rate Agency RMBS
|
5,995
|
|
|
5,995
|
|
|
—
|
|
|
—
|
|
||||
Non-Agency RMBS
|
(1,413
|
)
|
|
(1,433
|
)
|
|
(1
|
)
|
|
21
|
|
||||
|
$
|
(5,930
|
)
|
|
$
|
(6,507
|
)
|
|
$
|
356
|
|
|
$
|
221
|
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for RMBS and prepayment compensation, net of amortization for CMBS and CMBS IO.
|
|
|
Year Ended
|
||||||
|
|
December 31,
|
||||||
($ in thousands)
|
|
2017
|
|
2016
|
||||
Interest expense on repurchase agreement borrowings
|
|
$
|
36,345
|
|
|
$
|
24,191
|
|
Interest expense on FHLB advances
|
|
—
|
|
|
1,193
|
|
||
Accretion of de-designated cash flow hedges
(1)
|
|
(268
|
)
|
|
(251
|
)
|
||
Non-recourse collateralized financing
|
|
101
|
|
|
98
|
|
||
Total interest expense
|
|
$
|
36,178
|
|
|
$
|
25,231
|
|
|
|
|
|
|
|
|||
Average balance of repurchase agreements
|
|
$
|
2,691,650
|
|
|
$
|
2,659,809
|
|
Average balance of FHLB advances
|
|
—
|
|
|
244,967
|
|
||
Average balance of non-recourse collateralized financing
|
|
5,951
|
|
|
7,650
|
|
||
Average balance of borrowings
|
|
$
|
2,697,601
|
|
|
$
|
2,912,426
|
|
Cost of funds
(2)
|
|
1.32
|
%
|
|
0.85
|
%
|
(1)
|
Amount recorded in accordance with GAAP related to accretion of the balance remaining in accumulated other comprehensive income as a result of our discontinuation of cash flow hedge accounting effective June 30, 2013.
|
(2)
|
Cost of funds is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.
|
($ in thousands)
|
Year Ended
December 31, 2017 vs. December 31, 2016
|
||
Change in borrowing rates on repurchase agreements and FHLB advances
|
$
|
12,807
|
|
Change in average balance of repurchase agreements and FHLB advances
|
(1,846
|
)
|
|
Increase in accretion of de-designated cash flow hedges
|
(17
|
)
|
|
Decrease in non-recourse collateralized financing
|
3
|
|
|
Total increase in interest expense
|
$
|
10,947
|
|
|
Year Ended
|
||||||||||||
|
December 31,
|
||||||||||||
|
2017
|
|
2016
|
||||||||||
($ in thousands)
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
Interest income
|
$
|
94,502
|
|
|
3.06
|
%
|
|
$
|
91,898
|
|
|
2.82
|
%
|
Interest expense
|
36,178
|
|
|
1.32
|
%
|
|
25,231
|
|
|
0.85
|
%
|
||
Net interest income/spread
|
$
|
58,324
|
|
|
1.74
|
%
|
|
$
|
66,667
|
|
|
1.97
|
%
|
|
|
|
|
|
|
|
|
||||||
Average interest earning assets
(1)
|
$
|
3,052,372
|
|
|
|
|
$
|
3,236,903
|
|
|
|
||
Average balance of borrowings
(2)
|
$
|
2,697,601
|
|
|
|
|
$
|
2,912,426
|
|
|
|
(1)
|
Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.
|
(2)
|
Average balances are calculated as a simple average of the daily borrowings outstanding for both repurchase agreement and non-recourse collateralized financing.
|
|
|
Year Ended
|
||||||||||||||
|
|
December 31,
|
||||||||||||||
($ in thousands)
|
|
2017
|
|
2016
|
||||||||||||
Interest rate derivatives:
|
|
|
|
|
||||||||||||
Interest rate swaps:
|
|
|
|
|
||||||||||||
Net periodic interest costs
|
|
$
|
(3,417
|
)
|
|
$
|
(2,461
|
)
|
||||||||
Change in fair value
(1)
|
|
785
|
|
|
1,670
|
|
||||||||||
Total interest rate swap gains (losses), net
|
|
(2,632
|
)
|
|
(791
|
)
|
||||||||||
Eurodollar futures:
|
|
|
|
|
||||||||||||
Change in fair value
(1)
|
|
821
|
|
|
(4,815
|
)
|
||||||||||
TBA short positions (economic hedges):
|
|
|
|
|
||||||||||||
Change in fair value
(2)
|
|
(902
|
)
|
|
—
|
|
||||||||||
Total interest rate derivative gains (losses), net
|
|
(2,713
|
)
|
|
(5,606
|
)
|
||||||||||
|
|
|
|
|
||||||||||||
TBA dollar roll positions:
|
|
|
|
|
||||||||||||
TBA drop income
|
|
9,178
|
|
|
—
|
|
||||||||||
Change in fair value
(2)
|
|
(3,421
|
)
|
|
—
|
|
||||||||||
Total TBA dollar roll gains (losses), net
|
|
5,757
|
|
|
—
|
|
||||||||||
|
|
|
|
|
||||||||||||
Total gain (loss) on derivative instruments, net
|
|
$
|
3,044
|
|
|
$
|
(5,606
|
)
|
(1)
|
Changes in fair value for interest rate swaps and Eurodollar futures include unrealized gains (losses) from current and forward starting derivative instruments and realized gains (losses) from terminated derivative instruments.
|
(2)
|
Changes in fair value for TBA positions include unrealized gains (losses) from open TBA contracts and realized gains (losses) on paired off or terminated positions.
|
|
Year Ended
|
||||||||||||||
|
December 31,
|
||||||||||||||
|
2017
|
|
2016
|
||||||||||||
($ in thousands)
|
Amortized cost basis sold
|
|
(Loss) gain on sale of investments, net
|
|
Amortized cost basis sold
|
|
(Loss) gain on sale of investments, net
|
||||||||
Agency RMBS
|
$
|
728,952
|
|
|
$
|
(12,392
|
)
|
|
$
|
57,188
|
|
|
$
|
(3,010
|
)
|
Agency CMBS
|
252,759
|
|
|
(135
|
)
|
|
—
|
|
|
—
|
|
||||
Non-Agency CMBS
|
34,506
|
|
|
1,199
|
|
|
34,868
|
|
|
(1,228
|
)
|
||||
Non-Agency RMBS
|
16,365
|
|
|
42
|
|
|
—
|
|
|
—
|
|
||||
U.S. Treasuries
|
52,041
|
|
|
(244
|
)
|
|
|
|
|
||||||
|
$
|
1,084,623
|
|
|
$
|
(11,530
|
)
|
|
$
|
92,056
|
|
|
$
|
(4,238
|
)
|
|
Year Ended
|
||||||
|
December 31,
|
||||||
($ in thousands)
|
2017
|
|
2016
|
||||
Fixed-rate Agency RMBS
|
$
|
(4,592
|
)
|
|
$
|
—
|
|
Adjustable-rate Agency RMBS
|
9,398
|
|
|
2,709
|
|
||
Non-Agency RMBS
|
7
|
|
|
762
|
|
||
Agency CMBS
|
12,238
|
|
|
(16,640
|
)
|
||
Non-Agency CMBS
|
(3,169
|
)
|
|
(631
|
)
|
||
Agency CMBS IO
|
4,784
|
|
|
(4,110
|
)
|
||
Non-Agency CMBS IO
|
7,251
|
|
|
(1,680
|
)
|
||
U.S. Treasuries
|
(1,737
|
)
|
|
—
|
|
||
Unrealized gain (loss) on available-for-sale investments
|
$
|
24,180
|
|
|
$
|
(19,590
|
)
|
|
Year Ended
|
||||||||||||
|
December 31,
|
||||||||||||
|
2016
|
|
2015
|
||||||||||
($ in thousands)
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
RMBS:
|
|
|
|
|
|
|
|
||||||
Coupon and scheduled amortization
|
$
|
27,670
|
|
|
1.91
|
%
|
|
$
|
36,441
|
|
|
1.87
|
%
|
Prepayment adjustments
(1)
|
(1,962
|
)
|
|
(0.13
|
)%
|
|
(1,875
|
)
|
|
(0.10
|
)%
|
||
|
$
|
25,708
|
|
|
1.78
|
%
|
|
$
|
34,566
|
|
|
1.77
|
%
|
Average balance
(2)
|
$
|
1,446,479
|
|
|
|
|
$
|
1,951,178
|
|
|
|
||
|
|
|
|
|
|
|
|
||||||
CMBS:
|
|
|
|
|
|
|
|
||||||
Coupon and scheduled amortization
|
$
|
32,918
|
|
|
3.18
|
%
|
|
$
|
31,405
|
|
|
3.29
|
%
|
Prepayment adjustments
(1)
|
1,256
|
|
|
0.12
|
%
|
|
3,179
|
|
|
0.33
|
%
|
||
|
$
|
34,174
|
|
|
3.30
|
%
|
|
$
|
34,584
|
|
|
3.62
|
%
|
Average balance
(2)
|
$
|
1,021,960
|
|
|
|
|
$
|
946,214
|
|
|
|
||
|
|
|
|
|
|
|
|
||||||
CMBS IO:
|
|
|
|
|
|
|
|
||||||
Coupon and scheduled amortization
|
$
|
28,172
|
|
|
3.77
|
%
|
|
$
|
29,115
|
|
|
3.83
|
%
|
Prepayment adjustments
(1)
|
2,895
|
|
|
0.39
|
%
|
|
671
|
|
|
0.09
|
%
|
||
|
$
|
31,067
|
|
|
4.16
|
%
|
|
$
|
29,786
|
|
|
3.92
|
%
|
Average balance
(2)
|
$
|
746,458
|
|
|
|
|
$
|
758,921
|
|
|
|
||
|
|
|
|
|
|
|
|
||||||
Total MBS interest income and effective yield:
|
$
|
90,949
|
|
|
2.82
|
%
|
|
$
|
98,936
|
|
|
2.70
|
%
|
|
|
|
|
|
|
|
|
||||||
Total average balance
(2)
:
|
$
|
3,214,897
|
|
|
|
|
$
|
3,656,313
|
|
|
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for RMBS and prepayment compensation, net of amortization for CMBS and CMBS IO.
|
(2)
|
Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.
|
|
Year Ended
|
||||||||||||||
|
December 31, 2016 vs. December 31, 2015
|
||||||||||||||
|
Increase (Decrease) in Interest Income
|
|
Due to Change In
|
||||||||||||
($ in thousands)
|
|
Average Balance
|
|
Coupon and Scheduled Amortization
|
|
Prepayment Adjustments
(1)
|
|||||||||
RMBS
|
$
|
(8,858
|
)
|
|
$
|
(9,426
|
)
|
|
$
|
655
|
|
|
$
|
(87
|
)
|
CMBS
|
(410
|
)
|
|
2,492
|
|
|
(979
|
)
|
|
(1,923
|
)
|
||||
CMBS IO
|
1,281
|
|
|
(477
|
)
|
|
(466
|
)
|
|
2,224
|
|
||||
Total
|
$
|
(7,987
|
)
|
|
$
|
(7,411
|
)
|
|
$
|
(790
|
)
|
|
$
|
214
|
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for RMBS and prepayment compensation, net of amortization for CMBS and CMBS IO.
|
|
Year Ended
|
||||||
|
December 31,
|
||||||
($ in thousands)
|
2016
|
|
2015
|
||||
Interest expense on repurchase agreement borrowings
|
$
|
24,191
|
|
|
$
|
18,467
|
|
Interest expense on FHLB advances
|
1,193
|
|
|
541
|
|
||
(Accretion) amortization of de-designated cash flow hedges
(1)
|
(251
|
)
|
|
3,499
|
|
||
Non-recourse collateralized financing
|
98
|
|
|
98
|
|
||
Total interest expense
|
$
|
25,231
|
|
|
$
|
22,605
|
|
|
|
|
|
||||
Average balance of repurchase agreements
|
$
|
2,659,809
|
|
|
$
|
3,096,888
|
|
Average balance of FHLB advances
|
244,967
|
|
|
163,489
|
|
||
Average balance of non-recourse collateralized financing
|
7,650
|
|
|
9,334
|
|
||
Average balance of borrowings
|
$
|
2,912,426
|
|
|
$
|
3,269,711
|
|
Cost of funds
(2)
|
0.85
|
%
|
|
0.68
|
%
|
(1)
|
Amount recorded in accordance with GAAP related to accretion or amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.
|
(2)
|
Cost of funds is calculated by dividing total interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.
|
($ in thousands)
|
Year Ended
December 31, 2016 vs. December 31, 2015
|
||
Change in borrowing rates on repurchase agreements and FHLB advances
|
$
|
8,449
|
|
Change in average balance of repurchase agreements and FHLB advances
|
(2,073
|
)
|
|
Increase in accretion of de-designated cash flow hedges
|
(3,750
|
)
|
|
Decrease in non-recourse collateralized financing
|
—
|
|
|
Total increase in interest expense
|
$
|
2,626
|
|
|
Year Ended
|
||||||||||||
|
December 31,
|
||||||||||||
|
2016
|
|
2015
|
||||||||||
($ in thousands)
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
Interest income
|
$
|
91,898
|
|
|
2.82
|
%
|
|
$
|
100,244
|
|
|
2.71
|
%
|
Interest expense
|
25,231
|
|
|
0.85
|
%
|
|
22,605
|
|
|
0.68
|
%
|
||
Net interest income/spread
|
$
|
66,667
|
|
|
1.97
|
%
|
|
77,639
|
|
|
2.03
|
%
|
|
|
|
|
|
|
|
|
|
||||||
Average interest earning assets
(1)
|
$
|
3,236,903
|
|
|
|
|
$
|
3,685,936
|
|
|
|
||
Average balance of borrowings
(2)
|
$
|
2,912,426
|
|
|
|
|
$
|
3,269,711
|
|
|
|
(1)
|
Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.
|
(2)
|
Average balances are calculated as a simple average of the daily borrowings outstanding for both repurchase agreement and non-recourse collateralized financing.
|
|
Year Ended
|
||||||||||||||||||||||
|
December 31,
|
||||||||||||||||||||||
($ in thousands)
|
2016
|
|
2015
|
||||||||||||||||||||
Type of Derivative Instrument
|
Net Periodic Interest Costs
|
|
Change in Fair Value
(1)
|
|
Total
|
|
Net Periodic Interest Costs
|
|
Change in Fair Value
(1)
|
|
Total
|
||||||||||||
Receive-fixed interest rate swaps
|
$
|
5,072
|
|
|
$
|
(2,557
|
)
|
|
$
|
2,515
|
|
|
$
|
5,036
|
|
|
$
|
1,486
|
|
|
$
|
6,522
|
|
Pay-fixed interest rate swaps
|
(7,533
|
)
|
|
4,227
|
|
|
(3,306
|
)
|
|
(10,766
|
)
|
|
(17,921
|
)
|
|
(28,687
|
)
|
||||||
Eurodollar futures
|
—
|
|
|
(4,815
|
)
|
|
(4,815
|
)
|
|
—
|
|
|
(20,963
|
)
|
|
(20,963
|
)
|
||||||
Loss on derivative instruments, net
|
$
|
(2,461
|
)
|
|
$
|
(3,145
|
)
|
|
$
|
(5,606
|
)
|
|
$
|
(5,730
|
)
|
|
$
|
(37,398
|
)
|
|
$
|
(43,128
|
)
|
(1)
|
Amount shown includes unrealized gains (losses) from current and forward starting derivative instruments and realized gains (losses) from terminated derivative instruments.
|
|
Year Ended
|
||||||
|
December 31,
|
||||||
($ in thousands)
|
2016
|
|
2015
|
||||
Average notional balance
(1)
|
$
|
488,128
|
|
|
$
|
567,767
|
|
Weighted average net pay-fixed rate
(1)
|
0.99
|
%
|
|
1.23
|
%
|
|
Year Ended
|
||||||||||||||
|
December 31,
|
||||||||||||||
|
2016
|
|
2015
|
||||||||||||
($ in thousands)
|
Amortized cost basis sold
|
|
(Loss) gain on sale of investments, net
|
|
Amortized cost basis sold
|
|
(Loss) gain on sale of investments, net
|
||||||||
Agency RMBS
|
$
|
57,187
|
|
|
$
|
(3,010
|
)
|
|
$
|
177,430
|
|
|
$
|
(2,865
|
)
|
Agency CMBS
|
—
|
|
|
—
|
|
|
149,964
|
|
|
(604
|
)
|
||||
Non-Agency CMBS
|
34,868
|
|
|
(1,228
|
)
|
|
31,341
|
|
|
(566
|
)
|
||||
Agency CMBS IO
|
—
|
|
|
—
|
|
|
43,398
|
|
|
1,698
|
|
||||
Non-Agency CMBS IO
|
—
|
|
|
—
|
|
|
48,766
|
|
|
1,359
|
|
||||
Total
|
$
|
92,055
|
|
|
$
|
(4,238
|
)
|
|
$
|
450,899
|
|
|
$
|
(978
|
)
|
|
Year Ended
|
||||||
|
December 31,
|
||||||
($ in thousands)
|
2016
|
|
2015
|
||||
Adjustable-rate Agency RMBS
|
$
|
2,709
|
|
|
$
|
(2,085
|
)
|
Non-Agency RMBS
|
762
|
|
|
(781
|
)
|
||
Agency CMBS
|
(16,640
|
)
|
|
(19,048
|
)
|
||
Non-Agency CMBS
|
(631
|
)
|
|
(101
|
)
|
||
Agency CMBS IO
|
(4,110
|
)
|
|
(7,902
|
)
|
||
Non-Agency CMBS IO
|
(1,680
|
)
|
|
(7,666
|
)
|
||
Unrealized (loss) gain on available-for-sale investments
|
$
|
(19,590
|
)
|
|
$
|
(37,583
|
)
|
|
Repurchase Agreements
|
|
TBA Dollar Roll Positions
(1)
|
||||||||||||||||
($ in thousands)
|
Balance Outstanding As of Quarter End
|
|
Average Balance Outstanding For the Quarter Ended
|
|
Maximum Balance Outstanding During the Quarter Ended
|
|
Balance Outstanding As of Quarter End
|
|
Average Balance Outstanding For the Quarter Ended
|
||||||||||
December 31, 2017
|
$
|
2,565,902
|
|
|
$
|
2,557,573
|
|
|
$
|
2,677,894
|
|
|
$
|
829,425
|
|
|
$
|
928,329
|
|
September 30, 2017
|
2,519,230
|
|
|
2,616,250
|
|
|
2,801,418
|
|
|
683,813
|
|
|
745,270
|
|
|||||
June 30, 2017
|
2,540,759
|
|
|
2,753,019
|
|
|
2,826,005
|
|
|
416,312
|
|
|
305,720
|
|
|||||
March 31, 2017
|
2,825,945
|
|
|
2,843,733
|
|
|
2,913,617
|
|
|
—
|
|
|
—
|
|
|||||
December 31, 2016
|
2,898,952
|
|
|
2,768,769
|
|
|
2,938,745
|
|
|
—
|
|
|
—
|
|
|||||
September 30, 2016
|
2,478,278
|
|
|
2,536,562
|
|
|
2,599,491
|
|
|
—
|
|
|
—
|
|
(1)
|
Balance outstanding as of quarter end and average balance outstanding for the quarter ended includes TBA dollar roll positions as reported at cost (as if settled). Does not include short TBA positions used to hedge interest rate risk exposure from fixed-rate Agency RMBS.
|
|
December 31, 2017
|
|
September 30, 2017
|
|
June 30, 2017
|
|
March 31, 2017
|
|
December 31, 2016
|
|||||
Agency CMBS and RMBS
|
4.9
|
%
|
|
5.0
|
%
|
|
5.0
|
%
|
|
5.0
|
%
|
|
5.0
|
%
|
Non-Agency CMBS and RMBS
|
15.0
|
%
|
|
15.0
|
%
|
|
18.0
|
%
|
|
15.8
|
%
|
|
16.3
|
%
|
CMBS IO
|
14.6
|
%
|
|
15.0
|
%
|
|
15.0
|
%
|
|
15.3
|
%
|
|
15.4
|
%
|
|
December 31, 2017
|
||||||
($ in thousands)
|
Amount Outstanding
|
|
Equity at Risk
|
||||
Well Fargo Bank, N.A. and affiliates
|
$
|
311,351
|
|
|
$
|
56,383
|
|
|
$
|
311,351
|
|
|
$
|
56,383
|
|
|
December 31, 2016
|
||||||
($ in thousands)
|
Amount Outstanding
|
|
Equity at Risk
|
||||
Well Fargo Bank, N.A. and affiliates
|
$
|
342,160
|
|
|
$
|
62,041
|
|
South Street Financial Corporation
|
597,394
|
|
|
38,770
|
|
||
JP Morgan Securities, LLC
|
212,921
|
|
|
35,658
|
|
||
|
$
|
1,152,475
|
|
|
$
|
136,469
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||
($ in thousands)
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
||||||||
North America
|
$
|
1,551,758
|
|
|
$
|
1,700,582
|
|
|
$
|
2,105,337
|
|
|
$
|
2,309,391
|
|
Asia
|
489,376
|
|
|
515,593
|
|
|
421,991
|
|
|
443,098
|
|
||||
Europe
|
524,768
|
|
|
548,924
|
|
|
371,624
|
|
|
397,351
|
|
||||
|
$
|
2,565,902
|
|
|
$
|
2,765,099
|
|
|
$
|
2,898,952
|
|
|
$
|
3,149,840
|
|
($ in thousands)
|
|
Payments due by period
|
||||||||||||||||||
Contractual Obligations:
|
|
Total
|
|
< 1 year
|
|
1-3 years
|
|
3-5 years
|
|
> 5 years
|
||||||||||
Repurchase agreements
(1)
|
|
$
|
2,608,774
|
|
|
$
|
2,608,774
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Non-recourse collateralized financing
(2)
|
|
5,596
|
|
|
1,602
|
|
|
2,167
|
|
|
1,183
|
|
|
644
|
|
|||||
Operating lease obligations
|
|
491
|
|
|
160
|
|
|
331
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
|
$
|
2,614,861
|
|
|
$
|
2,610,536
|
|
|
$
|
2,498
|
|
|
$
|
1,183
|
|
|
$
|
644
|
|
•
|
Our business and investment strategy including our ability to generate acceptable risk-adjusted returns and our target investment allocations;
|
•
|
Our views on conditions in the investment and credit markets;
|
•
|
Our views on the effect of actual or proposed actions of the U.S. Federal Reserve and the FOMC with respect to monetary policy (including the targeted Federal Funds Rate), and the potential impact of these actions on interest rates, inflation or unemployment;
|
•
|
The effect of regulatory initiatives of the Federal Reserve (including the FOMC), other financial regulators, and other central banks;
|
•
|
Our financing strategy including our target leverage ratios, our use of TBA dollar roll transactions, and anticipated trends in financing costs, and our hedging strategy including changes to the derivative instruments to which we are a party, and changes to government regulation of hedging instruments and our use of these instruments;
|
•
|
Our investment portfolio composition and target investments;
|
•
|
Our investment portfolio performance, including the fair value, yields, and forecasted prepayment speeds of our investments;
|
•
|
Our liquidity and ability to access financing, and the anticipated availability and cost of financing;
|
•
|
Our stock repurchase activity and the impact of stock repurchases;
|
•
|
Our use of and restrictions on using our tax NOL carryforward;
|
•
|
The status of pending litigation;
|
•
|
The competitive environment in the future, including competition for investments and the availability of financing;
|
•
|
Estimates of future interest expenses, including related to the Company’s repurchase agreements and derivative instruments;
|
•
|
The status and effect of legislative reforms and regulatory rule-making or review processes, and the status of reform efforts and other business developments in the repurchase agreement financing market;
|
•
|
Market, industry and economic trends, how these trends and related economic data may impact the behavior of market participants and financial regulators; and
|
•
|
Market interest rates and market spreads.
|
•
|
the risks and uncertainties referenced in this
Annual
Report on Form
10-K
, particularly those set forth under and incorporated by reference into Part II, Item 1A, “Risk Factors”;
|
•
|
our ability to find suitable reinvestment opportunities;
|
•
|
changes in domestic economic conditions;
|
•
|
changes in interest rates and interest rate spreads, including the repricing of interest-earning assets and interest-bearing liabilities;
|
•
|
our investment portfolio performance particularly as it relates to cash flow, prepayment rates and credit performance;
|
•
|
the impact on markets and asset prices from the Federal Reserve’s balance sheet normalization process through the reduction in its holdings of Agency RMBS and U.S. Treasuries;
|
•
|
actual or anticipated changes in Federal Reserve monetary policy or the monetary policy of other central banks;
|
•
|
adverse reactions in U.S. financial markets related to actions of foreign central banks or the economic performance of foreign economies including in particular China, Japan, the European Union, and the United Kingdom;
|
•
|
uncertainty concerning the long-term fiscal health and stability of the United States;
|
•
|
the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;
|
•
|
the cost and availability of new equity capital;
|
•
|
changes in our use of leverage;
|
•
|
changes to our investment strategy, operating policies, dividend policy or asset allocations;
|
•
|
the quality of performance of third-party servicer providers of our loans and loans underlying our securities;
|
•
|
the level of defaults by borrowers on loans we have securitized;
|
•
|
changes in our industry;
|
•
|
increased competition;
|
•
|
changes in government regulations affecting our business;
|
•
|
changes or volatility in the repurchase agreement financing markets and other credit markets;
|
•
|
changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;
|
•
|
uncertainty regarding continued government support of the U.S financial system and U.S. housing and real estate markets; or to reform the U.S. housing finance system including the resolution of the conservatorship of Fannie Mae and Freddie Mac;
|
•
|
the composition of the Board of Governors of the Federal Reserve System;
|
•
|
ownership shifts under Section 382 that further limit the use of our tax NOL carryforward; and
|
•
|
exposure to current and future claims and litigation.
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||
|
|
Percentage Change in
|
|
Percentage Change in
|
||||||||
Parallel Shift in Interest Rates
|
|
Market Value of Investments
(1)
|
|
Shareholders’ Equity
|
|
Net Interest Income and Net Periodic Interest Costs
(2)
|
|
Market Value of Investments
(1)
|
|
Shareholders’ Equity
|
|
Net Interest Income and Net Periodic Interest Costs
(2)
|
+100
|
|
(1.7)%
|
|
(10.0)%
|
|
(8.1)%
|
|
(0.6)%
|
|
(4.4)%
|
|
(42.4)%
|
+50
|
|
(0.7)%
|
|
(4.0)%
|
|
(3.2)%
|
|
(0.3)%
|
|
(1.9)%
|
|
(20.7)%
|
-50
|
|
0.3%
|
|
1.8%
|
|
0.7%
|
|
0.2%
|
|
1.2%
|
|
18.7%
|
(1)
|
Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.
|
(2)
|
Includes changes in net interest income as well as net periodic interest costs on our interest rate swaps recorded in “gain (loss) on derivatives instruments, net”.
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||
Basis Point Change in
|
|
Percentage Change in
|
||||||||
2-year UST
|
|
10-year UST
|
|
Market Value of Investments
(1)
|
|
Shareholders’ Equity
|
|
Market Value of Investments
(1)
|
|
Shareholders’ Equity
|
+25
|
|
+50
|
|
(0.5)%
|
|
(3.0)%
|
|
0.1%
|
|
0.5%
|
+25
|
|
+0
|
|
(0.2)%
|
|
(0.9)%
|
|
(0.4)%
|
|
(2.5)%
|
+50
|
|
+25
|
|
(0.5)%
|
|
(2.8)%
|
|
(0.5)%
|
|
(3.2)%
|
+50
|
|
+100
|
|
(1.3)%
|
|
(7.7)%
|
|
0.1%
|
|
0.4%
|
-10
|
|
-50
|
|
0.1%
|
|
0.8%
|
|
(0.3)%
|
|
(2.3)%
|
(1)
|
Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.
|
Basis Point Change in Market Spreads
|
|
Percentage Change in Projected
Market Value of Investments
|
||
|
|
December 31, 2017
|
|
December 31, 2016
|
+50
|
|
(3.1)%
|
|
(2.2)%
|
+25
|
|
(1.1)%
|
|
(1.1)%
|
-25
|
|
1.6%
|
|
1.1%
|
-50
|
|
3.2%
|
|
2.3%
|
($ in thousands)
|
December 31, 2017
|
|
December 31, 2016
|
||||
Fannie Mae
|
$
|
10,419
|
|
|
$
|
18,957
|
|
Freddie Mac
|
369,886
|
|
|
392,941
|
|
||
Non-Agency CMBS IO
|
312,216
|
|
|
342,648
|
|
||
|
$
|
692,521
|
|
|
$
|
754,546
|
|
|
December 31, 2017
|
|
September 30, 2017
|
|
June 30, 2017
|
|
March 31, 2017
|
||||||||||||||||
($ in thousands)
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
||||||||
0-12 MTR
|
$
|
1,231
|
|
|
3.50%
|
|
$
|
1,313
|
|
|
3.44%
|
|
$
|
7,637
|
|
|
3.36%
|
|
$
|
17,671
|
|
|
3.24%
|
13-36 MTR
|
301
|
|
|
4.53%
|
|
182
|
|
|
4.52%
|
|
3,278
|
|
|
3.14%
|
|
7,307
|
|
|
3.07%
|
||||
37-60 MTR
|
8,114
|
|
|
3.11%
|
|
6,928
|
|
|
3.16%
|
|
11,074
|
|
|
3.07%
|
|
11,651
|
|
|
3.38%
|
||||
> 60 MTR
|
772
|
|
|
2.54%
|
|
2,588
|
|
|
2.58%
|
|
7,085
|
|
|
2.57%
|
|
11,744
|
|
|
2.68%
|
||||
30-year fixed-rate
(1)
|
35,602
|
|
|
3.72%
|
|
19,163
|
|
|
3.52%
|
|
—
|
|
|
—%
|
|
—
|
|
|
—%
|
||||
Total
|
$
|
46,020
|
|
|
3.56%
|
|
$
|
30,174
|
|
|
3.35%
|
|
$
|
29,074
|
|
|
2.98%
|
|
$
|
48,373
|
|
|
3.04%
|
Par balance
|
$
|
1,146,553
|
|
|
|
|
$
|
816,353
|
|
|
|
|
$
|
715,015
|
|
|
|
|
$
|
1,033,735
|
|
|
|
Premium, net as a % of par value
|
4.0
|
%
|
|
|
|
3.7
|
%
|
|
|
|
4.1
|
%
|
|
|
|
4.7
|
%
|
|
|
(1)
|
Excludes TBA securities which do not have prepayment risk.
|
ITEM 8.
|
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
ITEM 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
ITEM 9A.
|
CONTROLS AND PROCEDURES
|
ITEM 9B.
|
OTHER INFORMATION
|
ITEM 10.
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
ITEM 11.
|
EXECUTIVE COMPENSATION
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
|
Number of Securities to Be Issued upon Exercise of Outstanding Options, Warrants and Rights
|
|
Weighted-Average
Exercise Price of Outstanding Options, Warrants and Rights
|
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans
(1)
|
||||
Equity Compensation Plans Approved by Shareholders:
|
|
|
|
|
|
||||
2009 Stock and Incentive Plan
|
—
|
|
|
—
|
|
|
785,962
|
|
|
Equity Compensation Plans Not Approved by Shareholders
(2)
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
—
|
|
|
$
|
—
|
|
|
785,962
|
|
(1)
|
Reflects shares available to be granted under the 2009 Stock and Incentive Plan in the form of stock options, stock appreciation rights, stock awards, dividend equivalent rights, performance share awards, stock units and incentive awards.
|
(2)
|
The Company does not have any equity compensation plans that have not been approved by shareholders.
|
ITEM 13.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
|
ITEM 14.
|
PRINCIPAL ACCOUNANT FEES AND SERVICES
|
Exhibit No.
|
Description
|
3.1
|
|
3.2
|
|
10.11*
|
|
10.14
|
|
10.14.1
|
|
10.16*
|
|
10.18*
|
|
10.23
|
|
10.23.1
|
|
10.23.2
|
|
10.23.3
|
|
10.23.4
|
|
10.24
|
Exhibit No.
|
Description
|
10.25*
|
|
10.28*
|
|
10.29
|
|
10.30*
|
|
10.31*
|
|
10.32*
|
|
10.33*
|
|
10.34
|
|
10.34.1
|
|
12.1
|
|
21.1
|
|
23.1
|
|
31.1
|
|
31.2
|
|
32.1
|
|
101
|
The following materials from Dynex Capital, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2017, formatted in XBRL (Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income (Loss), (iii) Consolidated Statements of Shareholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements.
|
|
DYNEX CAPITAL, INC.
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
March 5, 2018
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti, Executive Vice President, Chief Financial Officer and Chief Operating Officer
|
|
Signature
|
Title
|
Date
|
|
|
|
/s/ Byron L. Boston
|
Chief Executive Officer, President,
|
March 5, 2018
|
Byron L. Boston
|
Co-Chief Investment Officer, and Director
|
|
|
(Principal Executive Officer)
|
|
|
|
|
/s/ Stephen J. Benedetti
|
Executive Vice President, Chief Financial
|
March 5, 2018
|
Stephen J. Benedetti
|
Officer and Chief Operating Officer
|
|
|
(Principal Financial Officer)
|
|
|
|
|
/s/ Jeffrey L. Childress
|
Vice President and Controller
|
March 5, 2018
|
Jeffrey L. Childress
|
(Principal Accounting Officer)
|
|
|
|
|
/s/ Michael R. Hughes
|
Director
|
March 5, 2018
|
Michael R. Hughes
|
|
|
|
|
|
/s/ Barry A. Igdaloff
|
Director
|
March 5, 2018
|
Barry A. Igdaloff
|
|
|
|
|
|
/s/ Valerie A. Mosley
|
Director
|
March 5, 2018
|
Valerie A. Mosley
|
|
|
|
|
|
/s/ Robert A. Salcetti
|
Director
|
March 5, 2018
|
Robert A. Salcetti
|
|
|
|
Page
|
Reports of Independent Registered Public Accounting Firm
|
|
|
|
Financial Statements As of December 31, 2017 and December 31, 2016 and For the Years Ended December 31, 2017, December 31, 2016, and December 31, 2015:
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
Consolidated Statements of Comprehensive Income (Loss)
|
|
|
|
Consolidated Statements of Shareholders’ Equity
|
|
|
|
Consolidated Statements of Cash Flows
|
|
|
|
Notes to the Consolidated Financial Statements:
|
|
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||
ASSETS
|
|
|
|
||||
Investments in securities, at fair value:
|
|
|
|
||||
Mortgage-backed securities (including pledged of $2,640,884 and $3,150,610, respectively)
|
$
|
3,026,989
|
|
|
$
|
3,212,084
|
|
U.S. Treasuries (including pledged of $124,215 and $0, respectively)
|
146,530
|
|
|
—
|
|
||
|
|
|
|
||||
Mortgage loans held for investment, net
|
15,738
|
|
|
19,036
|
|
||
Cash and cash equivalents
|
40,867
|
|
|
74,120
|
|
||
Restricted cash
|
46,333
|
|
|
24,769
|
|
||
Derivative assets
|
2,940
|
|
|
28,534
|
|
||
Principal receivable on investments
|
165
|
|
|
11,978
|
|
||
Accrued interest receivable
|
19,819
|
|
|
20,396
|
|
||
Other assets, net
|
6,397
|
|
|
6,814
|
|
||
Total assets
|
$
|
3,305,778
|
|
|
$
|
3,397,731
|
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
||
Liabilities:
|
|
|
|
|
|
||
Repurchase agreements
|
$
|
2,565,902
|
|
|
$
|
2,898,952
|
|
Payable for unsettled securities
|
156,899
|
|
|
—
|
|
||
Non-recourse collateralized financing
|
5,520
|
|
|
6,440
|
|
||
Derivative liabilities
|
269
|
|
|
6,922
|
|
||
Accrued interest payable
|
3,734
|
|
|
3,156
|
|
||
Accrued dividends payable
|
12,526
|
|
|
12,268
|
|
||
Other liabilities
|
3,870
|
|
|
2,809
|
|
||
Total liabilities
|
2,748,720
|
|
|
2,930,547
|
|
||
|
|
|
|
|
|||
Shareholders’ equity:
|
|
|
|
|
|
||
Preferred stock, par value $.01 per share; 50,000,000 shares authorized; 5,888,680 and 4,571,937 shares issued and outstanding, respectively ($147,217 and $114,298 aggregate liquidation preference, respectively)
|
$
|
141,294
|
|
|
$
|
110,005
|
|
Common stock, par value $.01 per share, 200,000,000 shares authorized;
55,831,549 and 49,153,463 shares issued and outstanding, respectively
|
558
|
|
|
492
|
|
||
Additional paid-in capital
|
775,873
|
|
|
727,369
|
|
||
Accumulated other comprehensive loss
|
(8,697
|
)
|
|
(32,609
|
)
|
||
Accumulated deficit
|
(351,970
|
)
|
|
(338,073
|
)
|
||
Total shareholders’ equity
|
557,058
|
|
|
467,184
|
|
||
Total liabilities and shareholders’ equity
|
$
|
3,305,778
|
|
|
$
|
3,397,731
|
|
|
Year Ended
|
||||||||||
|
December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Interest income
|
$
|
94,502
|
|
|
$
|
91,898
|
|
|
$
|
100,244
|
|
Interest expense
|
36,178
|
|
|
25,231
|
|
|
22,605
|
|
|||
Net interest income
|
58,324
|
|
|
66,667
|
|
|
77,639
|
|
|||
|
|
|
|
|
|
||||||
Gain (loss) on derivative instruments, net
|
3,044
|
|
|
(5,606
|
)
|
|
(43,128
|
)
|
|||
Loss on sale of investments, net
|
(11,530
|
)
|
|
(4,238
|
)
|
|
(978
|
)
|
|||
Fair value adjustments, net
|
75
|
|
|
103
|
|
|
69
|
|
|||
Other (loss) income, net
|
(201
|
)
|
|
880
|
|
|
610
|
|
|||
General and administrative expenses:
|
|
|
|
|
|
|
|||||
Compensation and benefits
|
(8,509
|
)
|
|
(7,550
|
)
|
|
(9,103
|
)
|
|||
Other general and administrative
|
(7,310
|
)
|
|
(7,157
|
)
|
|
(8,565
|
)
|
|||
Net income
|
33,893
|
|
|
43,099
|
|
|
16,544
|
|
|||
Preferred stock dividends
|
(10,794
|
)
|
|
(9,185
|
)
|
|
(9,176
|
)
|
|||
Net income to common shareholders
|
$
|
23,099
|
|
|
$
|
33,914
|
|
|
$
|
7,368
|
|
|
|
|
|
|
|
||||||
Other comprehensive income:
|
|
|
|
|
|
|
|||||
Unrealized gain (loss) on available-for-sale investments, net
|
$
|
12,650
|
|
|
$
|
(23,828
|
)
|
|
$
|
(38,561
|
)
|
Reclassification adjustment for loss on sale of investments, net
|
11,530
|
|
|
4,238
|
|
|
978
|
|
|||
Reclassification adjustment for de-designated cash flow hedges
|
(268
|
)
|
|
(251
|
)
|
|
3,499
|
|
|||
Total other comprehensive income (loss)
|
23,912
|
|
|
(19,841
|
)
|
|
(34,084
|
)
|
|||
Comprehensive income (loss) to common shareholders
|
$
|
47,011
|
|
|
$
|
14,073
|
|
|
$
|
(26,716
|
)
|
|
|
|
|
|
|
||||||
Net income per common share-basic and diluted
|
$
|
0.46
|
|
|
$
|
0.69
|
|
|
$
|
0.14
|
|
Weighted average common shares-basic and diluted
|
50,417
|
|
|
49,114
|
|
|
52,847
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Accumulated
Deficit
|
|
Total Shareholders’ Equity
|
||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||
Balance as of
December 31, 2014
|
4,550,000
|
|
$
|
109,658
|
|
|
54,739,111
|
|
$
|
547
|
|
|
$
|
763,935
|
|
|
$
|
21,316
|
|
|
$
|
(288,154
|
)
|
|
$
|
607,302
|
|
Stock issuance
|
—
|
|
—
|
|
|
22,607
|
|
—
|
|
|
166
|
|
|
—
|
|
|
—
|
|
|
166
|
|
||||||
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
263,829
|
|
3
|
|
|
2,962
|
|
|
—
|
|
|
—
|
|
|
2,965
|
|
||||||
Adjustments for tax withholding on share-based compensation
|
—
|
|
—
|
|
|
(67,296
|
)
|
(1
|
)
|
|
(556
|
)
|
|
—
|
|
|
—
|
|
|
(557
|
)
|
||||||
Stock issuance costs
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
(37
|
)
|
|
—
|
|
|
—
|
|
|
(37
|
)
|
||||||
Common stock repurchased
|
—
|
|
—
|
|
|
(5,910,916
|
)
|
(59
|
)
|
|
(41,112
|
)
|
|
—
|
|
|
—
|
|
|
(41,171
|
)
|
||||||
Net income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,544
|
|
|
16,544
|
|
||||||
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,176
|
)
|
|
(9,176
|
)
|
||||||
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(49,927
|
)
|
|
(49,927
|
)
|
||||||
Other comprehensive loss
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
(34,084
|
)
|
|
—
|
|
|
(34,084
|
)
|
||||||
Balance as of
December 31, 2015
|
4,550,000
|
|
$
|
109,658
|
|
|
49,047,335
|
|
$
|
490
|
|
|
$
|
725,358
|
|
|
$
|
(12,768
|
)
|
|
$
|
(330,713
|
)
|
|
$
|
492,025
|
|
Stock issuance
|
21,937
|
|
548
|
|
|
20,582
|
|
1
|
|
|
136
|
|
|
—
|
|
|
—
|
|
|
685
|
|
||||||
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
214,878
|
|
2
|
|
|
2,707
|
|
|
—
|
|
|
—
|
|
|
2,709
|
|
||||||
Adjustments for tax withholding on share-based compensation
|
—
|
|
—
|
|
|
(80,888
|
)
|
(1
|
)
|
|
(484
|
)
|
|
—
|
|
|
—
|
|
|
(485
|
)
|
||||||
Stock issuance costs
|
—
|
|
(201
|
)
|
|
—
|
|
—
|
|
|
(38
|
)
|
|
—
|
|
|
—
|
|
|
(239
|
)
|
||||||
Common stock repurchased
|
—
|
|
—
|
|
|
(48,444
|
)
|
—
|
|
|
(310
|
)
|
|
—
|
|
|
—
|
|
|
(310
|
)
|
||||||
Net income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
43,099
|
|
|
43,099
|
|
||||||
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,185
|
)
|
|
(9,185
|
)
|
||||||
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(41,274
|
)
|
|
(41,274
|
)
|
||||||
Other comprehensive loss
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
(19,841
|
)
|
|
—
|
|
|
(19,841
|
)
|
||||||
Balance as of
December 31, 2016
|
4,571,937
|
|
$
|
110,005
|
|
|
49,153,463
|
|
$
|
492
|
|
|
$
|
727,369
|
|
|
$
|
(32,609
|
)
|
|
$
|
(338,073
|
)
|
|
$
|
467,184
|
|
Stock issuance
|
1,316,743
|
|
31,350
|
|
|
6,617,487
|
|
66
|
|
|
47,116
|
|
|
—
|
|
|
—
|
|
|
78,532
|
|
||||||
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
138,166
|
|
1
|
|
|
1,953
|
|
|
—
|
|
|
—
|
|
|
1,954
|
|
||||||
Adjustments for tax withholding on share-based compensation
|
—
|
|
—
|
|
|
(77,567
|
)
|
(1
|
)
|
|
(520
|
)
|
|
—
|
|
|
—
|
|
|
(521
|
)
|
||||||
Stock issuance costs
|
—
|
|
(61
|
)
|
|
—
|
|
—
|
|
|
(45
|
)
|
|
—
|
|
|
—
|
|
|
(106
|
)
|
||||||
Net income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
33,893
|
|
|
33,893
|
|
||||||
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,794
|
)
|
|
(10,794
|
)
|
||||||
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(36,996
|
)
|
|
(36,996
|
)
|
||||||
Other comprehensive income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
23,912
|
|
|
—
|
|
|
23,912
|
|
||||||
Balance as of
December 31, 2017
|
5,888,680
|
|
$
|
141,294
|
|
|
55,831,549
|
|
$
|
558
|
|
|
$
|
775,873
|
|
|
$
|
(8,697
|
)
|
|
$
|
(351,970
|
)
|
|
$
|
557,058
|
|
|
Year Ended
|
||||||||||
|
December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Operating activities:
|
|
|
|
|
|
||||||
Net income
|
$
|
33,893
|
|
|
$
|
43,099
|
|
|
$
|
16,544
|
|
Adjustments to reconcile net income to cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|||
Decrease (increase) in accrued interest receivable
|
577
|
|
|
2,368
|
|
|
(1,607
|
)
|
|||
Increase (decrease) in accrued interest payable
|
578
|
|
|
1,413
|
|
|
(204
|
)
|
|||
(Gain) loss on derivative instruments, net
|
(3,044
|
)
|
|
5,606
|
|
|
43,128
|
|
|||
Loss on sale of investments, net
|
11,530
|
|
|
4,238
|
|
|
978
|
|
|||
Fair value adjustments, net
|
(75
|
)
|
|
(103
|
)
|
|
(69
|
)
|
|||
Amortization of investment premiums, net
|
157,706
|
|
|
150,729
|
|
|
152,308
|
|
|||
Other amortization and depreciation, net
|
1,287
|
|
|
1,502
|
|
|
5,338
|
|
|||
Stock-based compensation expense
|
1,954
|
|
|
2,709
|
|
|
2,965
|
|
|||
Increase (decrease) in other assets and liabilities, net
|
42
|
|
|
(1,047
|
)
|
|
(2,430
|
)
|
|||
Net cash and cash equivalents provided by operating activities
|
204,448
|
|
|
210,514
|
|
|
216,951
|
|
|||
Investing activities:
|
|
|
|
|
|
|
|
|
|||
Purchase of investments
|
(1,317,959
|
)
|
|
(435,046
|
)
|
|
(1,122,970
|
)
|
|||
Principal payments received on investments
|
307,133
|
|
|
448,567
|
|
|
494,275
|
|
|||
Proceeds from sales of investments
|
1,073,101
|
|
|
99,284
|
|
|
449,921
|
|
|||
Principal payments received on mortgage loans held for investment, net
|
3,386
|
|
|
4,953
|
|
|
15,570
|
|
|||
Payment to acquire interest in limited partnership
|
—
|
|
|
—
|
|
|
(6,000
|
)
|
|||
Distributions received from limited partnership
|
—
|
|
|
10,835
|
|
|
—
|
|
|||
Net receipts (payments) on derivatives, including terminations
|
21,986
|
|
|
(60,588
|
)
|
|
(39,929
|
)
|
|||
Other investing activities
|
(214
|
)
|
|
(37
|
)
|
|
(237
|
)
|
|||
Net cash and cash equivalents provided by (used in) investing activities
|
87,433
|
|
|
67,968
|
|
|
(209,370
|
)
|
|||
Financing activities:
|
|
|
|
|
|
|
|
||||
Borrowings under repurchase agreements and FHLB advances
|
84,876,542
|
|
|
40,594,639
|
|
|
23,555,007
|
|
|||
Repayments of repurchase agreement borrowings and FHLB advances
|
(85,209,592
|
)
|
|
(40,805,107
|
)
|
|
(23,458,697
|
)
|
|||
Principal payments on non-recourse collateralized financing
|
(938
|
)
|
|
(2,039
|
)
|
|
(2,395
|
)
|
|||
Proceeds from issuance of preferred stock
|
31,350
|
|
|
548
|
|
|
—
|
|
|||
Proceeds from issuance of common stock
|
47,182
|
|
|
137
|
|
|
166
|
|
|||
Cash paid for stock issuance costs
|
(61
|
)
|
|
(201
|
)
|
|
—
|
|
|||
Cash paid for repurchases of common stock
|
—
|
|
|
(310
|
)
|
|
(41,171
|
)
|
|||
Payments related to tax withholding for stock-based compensation
|
(521
|
)
|
|
(485
|
)
|
|
(557
|
)
|
|||
Dividends paid
|
(47,532
|
)
|
|
(51,900
|
)
|
|
(61,016
|
)
|
|||
Net cash and cash equivalents used in financing activities
|
(303,570
|
)
|
|
(264,718
|
)
|
|
(8,663
|
)
|
|||
|
|
|
|
|
|
||||||
Net (decrease) increase in cash, cash equivalents, and restricted cash
|
(11,689
|
)
|
|
13,764
|
|
|
(1,082
|
)
|
|||
Cash, cash equivalents, and restricted cash at beginning of period
|
98,889
|
|
|
85,125
|
|
|
86,207
|
|
|||
Cash, cash equivalents, and restricted cash at end of period
|
$
|
87,200
|
|
|
$
|
98,889
|
|
|
$
|
85,125
|
|
Supplemental Disclosure of Cash Activity:
|
|
|
|
|
|
|
|
||||
Cash paid for interest
|
$
|
35,851
|
|
|
$
|
24,033
|
|
|
$
|
19,260
|
|
|
|
December 31, 2017
|
||
Cash and cash equivalents
|
|
$
|
40,867
|
|
Restricted cash
|
|
46,333
|
|
|
Total cash, cash equivalents, and restricted cash shown on consolidated statement of cash flows
|
|
$
|
87,200
|
|
|
December 31, 2017
|
|||||||||||||||||||||||||
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC
(1)
|
|||||||||||||
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
(2)
|
$
|
1,146,553
|
|
|
$
|
46,021
|
|
|
$
|
1,192,574
|
|
|
$
|
1,626
|
|
|
$
|
(9,939
|
)
|
|
$
|
1,184,261
|
|
|
3.56
|
%
|
Non-Agency
|
1,070
|
|
|
—
|
|
|
1,070
|
|
|
41
|
|
|
(20
|
)
|
|
1,091
|
|
|
6.75
|
%
|
||||||
|
1,147,623
|
|
|
46,021
|
|
|
1,193,644
|
|
|
1,667
|
|
|
(9,959
|
)
|
|
1,185,352
|
|
|
|
|||||||
CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
1,123,967
|
|
|
10,442
|
|
|
1,134,409
|
|
|
3,514
|
|
|
(13,572
|
)
|
|
1,124,351
|
|
|
3.03
|
%
|
||||||
Non-Agency
|
26,501
|
|
|
(4,035
|
)
|
|
22,466
|
|
|
2,298
|
|
|
—
|
|
|
24,764
|
|
|
5.47
|
%
|
||||||
|
1,150,468
|
|
|
6,407
|
|
|
1,156,875
|
|
|
5,812
|
|
|
(13,572
|
)
|
|
1,149,115
|
|
|
|
|||||||
CMBS IO
(3)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
—
|
|
|
375,361
|
|
|
375,361
|
|
|
5,238
|
|
|
(293
|
)
|
|
380,306
|
|
|
0.62
|
%
|
||||||
Non-Agency
|
—
|
|
|
308,472
|
|
|
308,472
|
|
|
4,468
|
|
|
(724
|
)
|
|
312,216
|
|
|
0.61
|
%
|
||||||
|
—
|
|
|
683,833
|
|
|
683,833
|
|
|
9,706
|
|
|
(1,017
|
)
|
|
692,522
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasuries:
|
148,400
|
|
|
(133
|
)
|
|
148,267
|
|
|
—
|
|
|
(1,737
|
)
|
|
146,530
|
|
|
2.13
|
%
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total AFS securities:
|
$
|
2,446,491
|
|
|
$
|
736,128
|
|
|
$
|
3,182,619
|
|
|
$
|
17,185
|
|
|
$
|
(26,285
|
)
|
|
$
|
3,173,519
|
|
|
|
(1)
|
The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).
|
(2)
|
Includes purchased securities pending settlement.
|
(3)
|
The notional balance for Agency CMBS IO and non-Agency CMBS IO was
$14,196,122
and
$11,006,463
, respectively, as of
December 31, 2017
.
|
|
December 31, 2016
|
|||||||||||||||||||||||||
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC
(1)
|
|||||||||||||
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
$
|
1,157,258
|
|
|
$
|
57,066
|
|
|
$
|
1,214,324
|
|
|
$
|
2,832
|
|
|
$
|
(15,951
|
)
|
|
$
|
1,201,205
|
|
|
3.05
|
%
|
Non-Agency
|
33,572
|
|
|
(24
|
)
|
|
33,548
|
|
|
64
|
|
|
(50
|
)
|
|
33,562
|
|
|
3.58
|
%
|
||||||
|
1,190,830
|
|
|
57,042
|
|
|
1,247,872
|
|
|
2,896
|
|
|
(16,001
|
)
|
|
1,234,767
|
|
|
|
|||||||
CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
1,152,586
|
|
|
13,868
|
|
|
1,166,454
|
|
|
6,209
|
|
|
(28,108
|
)
|
|
1,144,555
|
|
|
3.12
|
%
|
||||||
Non-Agency
|
79,467
|
|
|
(6,718
|
)
|
|
72,749
|
|
|
5,467
|
|
|
—
|
|
|
78,216
|
|
|
4.72
|
%
|
||||||
|
1,232,053
|
|
|
7,150
|
|
|
1,239,203
|
|
|
11,676
|
|
|
(28,108
|
)
|
|
1,222,771
|
|
|
|
|||||||
CMBS IO
(2)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
—
|
|
|
411,737
|
|
|
411,737
|
|
|
3,523
|
|
|
(3,362
|
)
|
|
411,898
|
|
|
0.67
|
%
|
||||||
Non-Agency
|
—
|
|
|
346,155
|
|
|
346,155
|
|
|
1,548
|
|
|
(5,055
|
)
|
|
342,648
|
|
|
0.61
|
%
|
||||||
|
—
|
|
|
757,892
|
|
|
757,892
|
|
|
5,071
|
|
|
(8,417
|
)
|
|
754,546
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Total AFS securities:
|
$
|
2,422,883
|
|
|
$
|
822,084
|
|
|
$
|
3,244,967
|
|
|
$
|
19,643
|
|
|
$
|
(52,526
|
)
|
|
$
|
3,212,084
|
|
|
|
|
(1)
|
The WAC is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).
|
(2)
|
The notional balance for the Agency CMBS IO and non-Agency CMBS IO was
$13,106,912
and
$10,884,964
, respectively, as of
December 31, 2016
.
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
Less than 1 year
|
|
$
|
4,480
|
|
|
$
|
4,542
|
|
|
$
|
12,375
|
|
|
$
|
12,189
|
|
>
1 and <5 years
|
|
208,046
|
|
|
210,727
|
|
|
228,443
|
|
|
235,059
|
|
||||
>
5 and <10 years
|
|
1,334,795
|
|
|
1,326,178
|
|
|
1,060,273
|
|
|
1,040,609
|
|
||||
>
10 years
|
|
1,635,298
|
|
|
1,632,072
|
|
|
1,943,876
|
|
|
1,924,227
|
|
||||
|
|
$
|
3,182,619
|
|
|
$
|
3,173,519
|
|
|
$
|
3,244,967
|
|
|
$
|
3,212,084
|
|
|
Year Ended
|
||||||||||||||||||||||
|
December 31,
|
||||||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||||||||||||||
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
||||||||||||
Agency RMBS
|
$
|
716,560
|
|
|
$
|
(12,392
|
)
|
|
$
|
54,178
|
|
|
$
|
(3,010
|
)
|
|
$
|
174,565
|
|
|
$
|
(2,865
|
)
|
Agency CMBS
|
252,624
|
|
|
(135
|
)
|
|
—
|
|
|
—
|
|
|
149,360
|
|
|
(604
|
)
|
||||||
Non-Agency CMBS
|
35,705
|
|
|
1,199
|
|
|
33,640
|
|
|
(1,228
|
)
|
|
30,775
|
|
|
(566
|
)
|
||||||
Non-Agency RMBS
|
16,407
|
|
|
42
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Agency CMBS IO
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
45,096
|
|
|
1,698
|
|
||||||
Non-Agency CMBS IO
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
50,125
|
|
|
1,359
|
|
||||||
U.S. Treasuries
|
51,797
|
|
|
(244
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
$
|
1,073,093
|
|
|
$
|
(11,530
|
)
|
|
$
|
87,818
|
|
|
$
|
(4,238
|
)
|
|
$
|
449,921
|
|
|
$
|
(978
|
)
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
||||||||
Continuous unrealized loss position for less than 12 months:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Agency MBS
|
$
|
1,293,798
|
|
|
$
|
(9,769
|
)
|
|
71
|
|
$
|
1,738,094
|
|
|
$
|
(38,469
|
)
|
|
133
|
Non-Agency MBS
|
51,406
|
|
|
(421
|
)
|
|
11
|
|
205,484
|
|
|
(2,773
|
)
|
|
48
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Continuous unrealized loss position for 12 months or longer:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Agency MBS
|
$
|
423,698
|
|
|
$
|
(14,035
|
)
|
|
30
|
|
$
|
427,405
|
|
|
$
|
(8,952
|
)
|
|
72
|
Non-Agency MBS
|
20,414
|
|
|
(323
|
)
|
|
12
|
|
81,660
|
|
|
(2,332
|
)
|
|
26
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||
Collateral Type
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
||||||||||
Agency RMBS
|
|
$
|
836,281
|
|
|
1.47
|
%
|
|
$
|
867,120
|
|
|
$
|
1,157,302
|
|
|
0.82
|
%
|
|
$
|
1,191,147
|
|
Non-Agency RMBS
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
26,149
|
|
|
1.98
|
%
|
|
31,952
|
|
||||
Agency CMBS
|
|
1,003,146
|
|
|
1.44
|
%
|
|
1,071,904
|
|
|
1,005,726
|
|
|
0.82
|
%
|
|
1,095,002
|
|
||||
Non-Agency CMBS
|
|
15,508
|
|
|
2.47
|
%
|
|
18,212
|
|
|
66,881
|
|
|
1.63
|
%
|
|
77,840
|
|
||||
Agency CMBS IO
|
|
324,163
|
|
|
2.17
|
%
|
|
372,077
|
|
|
346,892
|
|
|
1.57
|
%
|
|
407,481
|
|
||||
Non-Agency CMBS IO
|
|
263,694
|
|
|
2.43
|
%
|
|
311,571
|
|
|
291,199
|
|
|
1.67
|
%
|
|
341,139
|
|
||||
U.S. Treasuries
|
|
123,110
|
|
|
1.85
|
%
|
|
124,215
|
|
|
—
|
|
|
—
|
%
|
|
—
|
|
||||
Securitization financing bond
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
4,803
|
|
|
2.00
|
%
|
|
5,278
|
|
||||
Total repurchase agreements
|
|
$
|
2,565,902
|
|
|
1.67
|
%
|
|
$
|
2,765,099
|
|
|
$
|
2,898,952
|
|
|
1.03
|
%
|
|
$
|
3,149,839
|
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||
Remaining Term to Maturity
|
|
Balance
|
|
WAVG Original Term to Maturity
|
|
Balance
|
|
WAVG Original Term to Maturity
|
||||||
Less than 30 days
|
|
$
|
2,240,791
|
|
|
49
|
|
|
$
|
2,480,213
|
|
|
58
|
|
30 to 90 days
|
|
274,231
|
|
|
90
|
|
|
418,739
|
|
|
87
|
|
||
91 to 180 days
|
|
50,880
|
|
|
121
|
|
|
—
|
|
|
—
|
|
||
Total
|
|
$
|
2,565,902
|
|
|
54
|
|
|
$
|
2,898,952
|
|
|
63
|
|
|
|
December 31, 2017
|
|||||||||
Counterparty Name
|
|
Balance
|
|
Weighted Average Rate
|
|
Equity at Risk
|
|||||
Wells Fargo Bank, N. A. and affiliates
|
|
$
|
311,351
|
|
|
2.43
|
%
|
|
$
|
56,383
|
|
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchase agreements
|
$
|
2,565,902
|
|
|
$
|
—
|
|
|
$
|
2,565,902
|
|
|
$
|
(2,565,902
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchase agreements
|
$
|
2,898,952
|
|
|
$
|
—
|
|
|
$
|
2,898,952
|
|
|
$
|
(2,898,952
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
(1)
|
Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of debt securities up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented.
|
|
|
|
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||
Type of Derivative Instrument
|
|
Balance Sheet Location
|
|
Purpose
|
|
Fair Value
|
|
Fair Value
(1)
|
||||
Interest rate swaps
|
|
Derivative assets
|
|
Economic hedging
|
|
$
|
791
|
|
|
$
|
28,534
|
|
Eurodollar futures
(2)
|
|
Derivative assets
|
|
Economic hedging
|
|
666
|
|
|
—
|
|
||
TBA securities
|
|
Derivative assets
|
|
Investing
|
|
1,483
|
|
|
—
|
|
||
|
|
|
|
|
|
$
|
2,940
|
|
|
$
|
28,534
|
|
|
|
|
|
|
|
|
|
|
||||
Interest rate swaps
|
|
Derivative liabilities
|
|
Economic hedging
|
|
$
|
—
|
|
|
$
|
(6,922
|
)
|
TBA securities
|
|
Derivative liabilities
|
|
Economic hedging
|
|
(269
|
)
|
|
—
|
|
||
|
|
|
|
|
|
$
|
(269
|
)
|
|
$
|
(6,922
|
)
|
(1)
|
Refer to
Note 1
regarding information on a change in the CME rulebook. Amounts reported on the consolidated balance sheet as of
December 31, 2017
for its interest rate swaps reflect the netting of the derivative asset or liability with the related collateral received or posted, respectively. The net amounts comparable to
December 31, 2017
for the derivative asset and derivative liabilities as of December 31, 2016 were
$104
and
$(576)
, respectively.
|
(2)
|
The Eurodollar futures aggregate notional amount represents the total notional of the 3-month contracts with expiration dates from 2017 to 2018. The maximum notional outstanding for any future 3-month period did not exceed $650,000 as of December 31, 2017.
|
|
|
December 31, 2017
|
|||||||||||
|
|
|
|
Weighted-Average:
|
|
|
|||||||
Years to Maturity:
|
|
Net Notional Amount
(1)
|
|
Pay Rate
(2)
|
|
Life Remaining (in Years)
|
|
Fair Value
|
|||||
<
3 years
|
|
$
|
3,320,000
|
|
|
1.35
|
%
|
|
0.7
|
|
$
|
791
|
|
>3 and
<
6 years
|
|
1,210,000
|
|
|
2.00
|
%
|
|
4.6
|
|
—
|
|
||
>6 and
<
10 years
|
|
1,025,000
|
|
|
2.49
|
%
|
|
8.0
|
|
—
|
|
||
>10 years
|
|
120,000
|
|
|
2.75
|
%
|
|
17.3
|
|
—
|
|
||
Total
|
|
$
|
5,675,000
|
|
|
1.71
|
%
|
|
3.1
|
|
$
|
791
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
December 31, 2016
|
|||||||||||
|
|
|
|
Weighted-Average:
|
|
|
|||||||
Years to Maturity:
|
|
Net Notional Amount
(1)
|
|
Pay Rate
(2)
|
|
Life Remaining (in Years)
|
|
Fair Value
|
|||||
<
3 years
|
|
$
|
595,000
|
|
|
0.73
|
%
|
|
2.3
|
|
$
|
4,348
|
|
>3 and
<
6 years
|
|
1,185,000
|
|
|
1.47
|
%
|
|
4.3
|
|
8,631
|
|
||
>6 and
<
10 years
|
|
1,250,000
|
|
|
2.42
|
%
|
|
8.9
|
|
8,633
|
|
||
Total
|
|
$
|
3,030,000
|
|
|
1.58
|
%
|
|
5.3
|
|
$
|
21,612
|
|
(1)
|
The net notional amounts included in the tables above represent pay-fixed interest rate swaps, net of receive-fixed interest rate swaps and include
$2,525,000
and
$2,725,000
of pay-fixed forward starting interest rate swaps as of
December 31, 2017
and
December 31, 2016
, respectively.
|
|
|
December 31, 2017
|
||||||||||||||
|
|
Notional Amount
(1)
|
|
Implied Cost Basis
(2)
|
|
Implied Market Value
(3)
|
|
Net Carrying Value
(4)
|
||||||||
Dollar roll positions:
|
|
|
|
|
|
|
|
|
||||||||
30-year 4.0% TBA securities
|
|
$
|
795,000
|
|
|
$
|
829,425
|
|
|
$
|
830,908
|
|
|
$
|
1,483
|
|
|
|
|
|
|
|
|
|
|
||||||||
Economic hedges:
|
|
|
|
|
|
|
|
|
||||||||
30-year 3.5% TBA securities
|
|
$
|
150,000
|
|
|
$
|
(153,797
|
)
|
|
$
|
(154,066
|
)
|
|
$
|
(269
|
)
|
(1)
|
Notional amount represents the par value (or principal balance) of the underlying Agency MBS as if settled as of the end of the period.
|
(2)
|
Implied cost basis represents the forward price to be paid for the underlying Agency MBS as if settled as of end of the period.
|
(3)
|
Implied market value represents the estimated fair value of the underlying Agency MBS as if settled as of the end of the period.
|
(4)
|
Net carrying value represents the difference between the implied market value and the implied cost basis of the TBA security as of the end of the period and is included on the consolidated balance sheets within “derivative assets (liabilities)”.
|
Type of Derivative Instrument
|
|
Notional Amount as of December 31, 2016
|
|
Additions
|
|
Settlements,
Terminations,
or Pair-Offs
|
|
Notional Amount as of December 31, 2017
|
||||||||
Receive-fixed interest rate swaps
|
|
$
|
425,000
|
|
|
$
|
—
|
|
|
$
|
(325,000
|
)
|
|
$
|
100,000
|
|
Pay-fixed interest rate swaps
|
|
3,455,000
|
|
|
3,890,000
|
|
|
(1,570,000
|
)
|
|
5,775,000
|
|
||||
Eurodollar futures
|
|
—
|
|
|
2,600,000
|
|
|
(650,000
|
)
|
|
1,950,000
|
|
||||
TBA dollar roll positions
|
|
—
|
|
|
6,729,000
|
|
|
(5,934,000
|
)
|
|
795,000
|
|
||||
TBA economic hedges
|
|
—
|
|
|
(250,000
|
)
|
|
100,000
|
|
|
(150,000
|
)
|
|
|
Year Ended
|
||||||||||
|
|
December 31,
|
||||||||||
Type of Derivative Instrument
|
|
2017
|
|
2016
|
|
2015
|
||||||
Receive-fixed interest rate swaps
|
|
$
|
23
|
|
|
$
|
2,515
|
|
|
$
|
6,522
|
|
Pay-fixed interest rate swaps
|
|
(2,655
|
)
|
|
(3,306
|
)
|
|
(28,687
|
)
|
|||
Eurodollar futures
|
|
821
|
|
|
(4,815
|
)
|
|
(20,963
|
)
|
|||
TBA dollar roll positions
|
|
5,757
|
|
|
—
|
|
|
—
|
|
|||
TBA economic hedges
|
|
(902
|
)
|
|
—
|
|
|
—
|
|
|||
Gain (loss) on derivative instruments, net
|
|
$
|
3,044
|
|
|
$
|
(5,606
|
)
|
|
$
|
(43,128
|
)
|
|
Offsetting of Assets
|
||||||||||||||||||||||
|
Gross Amount of Recognized Assets
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Assets Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Received as Collateral
|
|
Cash Received as Collateral
|
|||||||||||||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
791
|
|
|
$
|
—
|
|
|
$
|
791
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
791
|
|
Eurodollar Futures
|
666
|
|
|
—
|
|
|
666
|
|
|
—
|
|
|
(666
|
)
|
|
—
|
|
||||||
TBA securities
|
1,483
|
|
|
—
|
|
|
1,483
|
|
|
(180
|
)
|
|
—
|
|
|
1,303
|
|
||||||
Derivative assets
|
$
|
2,940
|
|
|
$
|
—
|
|
|
$
|
2,940
|
|
|
$
|
(180
|
)
|
|
$
|
(666
|
)
|
|
$
|
2,094
|
|
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
28,534
|
|
|
$
|
—
|
|
|
$
|
28,534
|
|
|
$
|
(6,449
|
)
|
|
$
|
(22,085
|
)
|
|
$
|
—
|
|
TBA securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Derivative assets
|
$
|
28,534
|
|
|
$
|
—
|
|
|
$
|
28,534
|
|
|
$
|
(6,449
|
)
|
|
$
|
(22,085
|
)
|
|
$
|
—
|
|
|
Offsetting of Liabilities
|
||||||||||||||||||||||
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
TBA securities
|
269
|
|
|
—
|
|
|
269
|
|
|
(180
|
)
|
|
—
|
|
|
89
|
|
||||||
Derivative liabilities
|
$
|
269
|
|
|
$
|
—
|
|
|
$
|
269
|
|
|
$
|
(180
|
)
|
|
$
|
—
|
|
|
$
|
89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
6,922
|
|
|
$
|
—
|
|
|
$
|
6,922
|
|
|
$
|
(6,913
|
)
|
|
$
|
—
|
|
|
$
|
9
|
|
TBA securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Derivative liabilities
|
$
|
6,922
|
|
|
$
|
—
|
|
|
$
|
6,922
|
|
|
$
|
(6,913
|
)
|
|
$
|
—
|
|
|
$
|
9
|
|
(1)
|
Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented.
|
•
|
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
|
•
|
Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.
|
•
|
Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
|
|
December 31, 2017
|
||||||||||||||
|
Fair Value
|
|
Level 1 - Unadjusted Quoted Prices in Active Markets
|
|
Level 2 - Observable Inputs
|
|
Level 3 - Unobservable Inputs
|
||||||||
Assets carried at fair value:
|
|
|
|
|
|
|
|
||||||||
Investments in securities:
|
|
|
|
|
|
|
|
||||||||
Mortgage-backed securities
|
$
|
3,026,989
|
|
|
$
|
—
|
|
|
$
|
3,019,746
|
|
|
$
|
7,243
|
|
U.S. Treasuries
|
146,530
|
|
|
146,530
|
|
|
—
|
|
|
—
|
|
||||
Derivative assets:
|
|
|
|
|
|
|
|
||||||||
Interest rate swaps
|
791
|
|
|
—
|
|
|
791
|
|
|
—
|
|
||||
Eurodollar futures
|
666
|
|
|
666
|
|
|
—
|
|
|
—
|
|
||||
TBA securities
|
1,483
|
|
|
—
|
|
|
1,483
|
|
|
—
|
|
||||
Total assets carried at fair value
|
$
|
3,176,459
|
|
|
$
|
147,196
|
|
|
$
|
3,022,020
|
|
|
$
|
7,243
|
|
|
|
|
|
|
|
|
|
||||||||
Liabilities carried at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
||||
TBA securities
|
269
|
|
|
—
|
|
|
269
|
|
|
—
|
|
||||
Total liabilities carried at fair value
|
$
|
269
|
|
|
$
|
—
|
|
|
$
|
269
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||||||
|
December 31, 2016
|
||||||||||||||
|
Fair Value
|
|
Level 1 - Unadjusted Quoted Prices in Active Markets
|
|
Level 2 - Observable Inputs
|
|
Level 3 - Unobservable Inputs
|
||||||||
Assets carried at fair value:
|
|
|
|
|
|
|
|
||||||||
Mortgage-backed securities
|
$
|
3,212,084
|
|
|
$
|
—
|
|
|
$
|
3,201,157
|
|
|
$
|
10,927
|
|
Interest rate swaps
|
28,534
|
|
|
—
|
|
|
28,534
|
|
|
—
|
|
||||
Total assets carried at fair value
|
$
|
3,240,618
|
|
|
$
|
—
|
|
|
$
|
3,229,691
|
|
|
$
|
10,927
|
|
Liabilities carried at fair value:
|
|
|
|
|
|
|
|
||||||||
Interest rate swaps
|
$
|
6,922
|
|
|
$
|
—
|
|
|
$
|
6,922
|
|
|
$
|
—
|
|
Total liabilities carried at fair value
|
$
|
6,922
|
|
|
$
|
—
|
|
|
$
|
6,922
|
|
|
$
|
—
|
|
|
Year Ended
|
||||||||||
|
December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Balance as of beginning of period
|
$
|
10,927
|
|
|
$
|
16,435
|
|
|
$
|
43,957
|
|
Unrealized (loss) gain included in OCI
(1)
|
(1,733
|
)
|
|
(1,057
|
)
|
|
2,608
|
|
|||
Principal payments
|
(4,351
|
)
|
|
(6,019
|
)
|
|
(30,602
|
)
|
|||
Accretion
|
2,400
|
|
|
1,568
|
|
|
472
|
|
|||
Balance as of end of period
|
$
|
7,243
|
|
|
$
|
10,927
|
|
|
$
|
16,435
|
|
(1)
|
Amount included in “unrealized gain (loss) on available-for-sale investments, net” on consolidated statements of comprehensive income (loss).
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||
|
Carrying Value
|
|
Fair Value
|
|
Carrying Value
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Mortgage-backed securities
|
$
|
3,026,989
|
|
|
$
|
3,026,989
|
|
|
$
|
3,212,084
|
|
|
$
|
3,212,084
|
|
U.S. Treasuries
|
146,530
|
|
|
146,530
|
|
|
—
|
|
|
—
|
|
||||
Mortgage loans held for investment, net
(1)
|
15,738
|
|
|
12,973
|
|
|
19,036
|
|
|
15,971
|
|
||||
Derivative assets
|
2,940
|
|
|
2,940
|
|
|
28,534
|
|
|
28,534
|
|
||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Repurchase agreements
(2)
|
$
|
2,565,902
|
|
|
$
|
2,565,902
|
|
|
$
|
2,898,952
|
|
|
$
|
2,898,952
|
|
Non-recourse collateralized financing
(1)
|
5,520
|
|
|
5,554
|
|
|
6,440
|
|
|
6,357
|
|
||||
Derivative liabilities
|
269
|
|
|
269
|
|
|
6,922
|
|
|
6,922
|
|
(1)
|
The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.
|
(2)
|
The carrying value of repurchase agreements generally approximates fair value due to their short term maturities.
|
|
Year Ended
|
|||||||||||||||||||
|
December 31,
|
|||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
|||||||||
Restricted stock outstanding as of beginning of period
|
553,396
|
|
|
$
|
7.55
|
|
|
696,597
|
|
|
$
|
8.54
|
|
|
731,809
|
|
|
$
|
8.89
|
|
Restricted stock granted
|
138,166
|
|
|
6.76
|
|
|
214,878
|
|
|
6.28
|
|
|
263,829
|
|
|
8.21
|
|
|||
Restricted stock vested
|
(338,459
|
)
|
|
7.80
|
|
|
(358,079
|
)
|
|
8.71
|
|
|
(299,041
|
)
|
|
9.12
|
|
|||
Restricted stock outstanding as of end of period
|
353,103
|
|
|
$
|
7.01
|
|
|
553,396
|
|
|
$
|
7.55
|
|
|
696,597
|
|
|
$
|
8.54
|
|
|
Year Ended December 31, 2017
|
||||||||||||||
|
First Quarter
|
|
Second Quarter
|
|
Third Quarter
|
|
Fourth Quarter
|
||||||||
Operating results:
|
|
|
|
|
|
|
|
||||||||
Interest income
|
$
|
22,419
|
|
|
$
|
24,856
|
|
|
$
|
23,103
|
|
|
$
|
24,124
|
|
Interest expense
|
7,519
|
|
|
8,714
|
|
|
9,889
|
|
|
10,056
|
|
||||
Net interest income
|
14,900
|
|
|
16,142
|
|
|
13,214
|
|
|
14,068
|
|
||||
Gain (loss) on derivatives instruments, net
|
175
|
|
|
(15,802
|
)
|
|
5,993
|
|
|
12,678
|
|
||||
Loss on sale of investments, net
|
(1,708
|
)
|
|
(3,709
|
)
|
|
(5,211
|
)
|
|
(902
|
)
|
||||
Fair value adjustments and other income (expense) amounts, net
|
(36
|
)
|
|
34
|
|
|
(86
|
)
|
|
(38
|
)
|
||||
General and administrative expenses
|
(4,280
|
)
|
|
(4,097
|
)
|
|
(3,599
|
)
|
|
(3,843
|
)
|
||||
Preferred stock dividends
|
(2,435
|
)
|
|
(2,641
|
)
|
|
(2,808
|
)
|
|
(2,910
|
)
|
||||
Net income (loss) to common shareholders
|
6,616
|
|
|
(10,073
|
)
|
|
7,503
|
|
|
19,053
|
|
||||
Other comprehensive income (loss)
|
19,977
|
|
|
12,375
|
|
|
6,144
|
|
|
(14,584
|
)
|
||||
Comprehensive income (loss) to common shareholders
|
$
|
26,593
|
|
|
$
|
2,302
|
|
|
$
|
13,647
|
|
|
$
|
4,469
|
|
Net income (loss) per common share
|
$
|
0.13
|
|
|
$
|
(0.20
|
)
|
|
$
|
0.15
|
|
|
$
|
0.36
|
|
Dividends declared per common share
|
$
|
0.18
|
|
|
$
|
0.18
|
|
|
$
|
0.18
|
|
|
$
|
0.18
|
|
|
|
|
|
|
|
|
|
||||||||
|
Year Ended December 31, 2016
|
||||||||||||||
|
First Quarter
|
|
Second Quarter
|
|
Third Quarter
|
|
Fourth Quarter
|
||||||||
Operating results:
|
|
|
|
|
|
|
|
||||||||
Interest income
|
$
|
25,089
|
|
|
$
|
22,816
|
|
|
$
|
21,135
|
|
|
$
|
22,858
|
|
Interest expense
|
6,310
|
|
|
6,100
|
|
|
6,068
|
|
|
6,753
|
|
||||
Net interest income
|
18,779
|
|
|
16,716
|
|
|
15,067
|
|
|
16,105
|
|
||||
(Loss) gain on derivatives instruments, net
|
(48,264
|
)
|
|
(16,297
|
)
|
|
2,409
|
|
|
56,546
|
|
||||
Loss on sale of investments, net
|
(3,941
|
)
|
|
(297
|
)
|
|
—
|
|
|
—
|
|
||||
Fair value adjustments and other income (expense) amounts, net
|
87
|
|
|
318
|
|
|
579
|
|
|
(1
|
)
|
||||
General and administrative expenses
|
(4,092
|
)
|
|
(3,671
|
)
|
|
(3,355
|
)
|
|
(3,589
|
)
|
||||
Preferred stock dividends
|
(2,294
|
)
|
|
(2,294
|
)
|
|
(2,294
|
)
|
|
(2,303
|
)
|
||||
Net (loss) income to common shareholders
|
(39,725
|
)
|
|
(5,525
|
)
|
|
12,406
|
|
|
66,758
|
|
||||
Other comprehensive income (loss)
|
41,728
|
|
|
22,947
|
|
|
670
|
|
|
(85,186
|
)
|
||||
Comprehensive income (loss) to common shareholders
|
$
|
2,003
|
|
|
$
|
17,422
|
|
|
$
|
13,076
|
|
|
$
|
(18,428
|
)
|
Net (loss) income per common share
|
$
|
(0.81
|
)
|
|
$
|
(0.11
|
)
|
|
$
|
0.25
|
|
|
$
|
1.36
|
|
Dividends declared per common share
|
$
|
0.21
|
|
|
$
|
0.21
|
|
|
$
|
0.21
|
|
|
$
|
0.21
|
|
Executive
|
Target Incentive Opportunity
|
Maximum Incentive Opportunity
|
CEO
|
200%
|
400%
|
EVP
|
150%
|
300%
|
Metric
|
Weighting (of incentive opportunity)
|
Return on Equity (ROE)
|
0% - 40%
|
Book value per common share
|
0% - 40%
|
Corporate/individual objectives
|
40%
|
Metric
|
Weighting (of incentive opportunity)
|
Total Economic Return (TER)
|
20%
|
|
Year Ended December 31,
|
||||||||||||||||||
($ in thousands, except ratios)
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Fixed charges:
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
$
|
36,178
|
|
|
$
|
25,231
|
|
|
$
|
22,605
|
|
|
$
|
25,915
|
|
|
$
|
39,028
|
|
Preferred dividend requirements
|
10,794
|
|
|
9,185
|
|
|
9,176
|
|
|
9,176
|
|
|
7,902
|
|
|||||
Total
|
$
|
46,972
|
|
|
$
|
34,416
|
|
|
$
|
31,781
|
|
|
$
|
35,091
|
|
|
$
|
46,930
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Earnings:
|
|
|
|
|
|
|
|
|
|
||||||||||
Income from continuing operations
|
$
|
33,893
|
|
|
$
|
43,099
|
|
|
$
|
16,544
|
|
|
$
|
27,806
|
|
|
$
|
68,069
|
|
Add:
|
|
|
|
|
|
|
|
|
|
||||||||||
Distributed income of equity method investee
|
—
|
|
|
1,316
|
|
|
—
|
|
|
—
|
|
|
721
|
|
|||||
Fixed charges, excluding preferred dividend requirements
|
36,178
|
|
|
25,231
|
|
|
22,605
|
|
|
25,915
|
|
|
39,028
|
|
|||||
Less: Equity in income of equity investee
|
—
|
|
|
(481
|
)
|
|
(835
|
)
|
|
—
|
|
|
(721
|
)
|
|||||
Total
|
$
|
70,071
|
|
|
$
|
69,165
|
|
|
$
|
38,314
|
|
|
$
|
53,721
|
|
|
$
|
107,097
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Ratio of earnings to fixed charges
|
1.94x
|
|
2.74x
|
|
1.69x
|
|
2.07x
|
|
2.74x
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Ratio of earnings to fixed charges and preferred stock dividends
|
1.49x
|
|
2.01x
|
|
1.21x
|
|
1.53x
|
|
2.28x
|
1.
|
I have reviewed this
Annual
Report on Form
10-K
of Dynex Capital, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
March 5, 2018
|
|
|
|
/s/ Byron L. Boston
|
|
|
Byron L. Boston
|
|
|
Principal Executive Officer
|
1.
|
I have reviewed this
Annual
Report on Form
10-K
of Dynex Capital, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
March 5, 2018
|
|
|
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti
|
|
|
Principal Financial Officer
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
March 5, 2018
|
/s/ Byron L. Boston
|
|
|
Byron L. Boston
|
|
|
Principal Executive Officer
|
|
|
|
|
|
|
Date:
|
March 5, 2018
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti
|
|
|
Principal Financial Officer
|